%PDF-1.3
%
2 0 obj
<>
endobj
18 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
6 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
13 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
19 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
3 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
14 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
15 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
16 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
10 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
11 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
7 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
17 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
4 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 55/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
12 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
9 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 54/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
8 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
1 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
5 0 obj
<>>>/Subtype/Form/BBox[0 0 612 792]/Matrix [1 0 0 1 0 0]/Length 53/FormType 1/Filter/FlateDecode>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
20 0 obj
<>stream
Arbortext Advanced Print Publisher 9.0.114/W
2011-04-20T14:20:20-07:00
2011-03-12T09:49:07+05:30
application/pdf
untitled
Acrobat Distiller 8.1.0 (Windows)
uuid:713cc604-ea45-41aa-ac94-8d13be62ce6e
uuid:b3a78990-e934-4bf1-b52d-6263b26bff02
endstream
endobj
21 0 obj
<>stream
x+ |
endstream
endobj
22 0 obj
<>stream
xS**T0T0 BiU !D. _e1
endstream
endobj
23 0 obj
<>stream
x+ |
endstream
endobj
24 0 obj
<>stream
xS**T0T0 Bih] D. pa
endstream
endobj
25 0 obj
<>stream
x+ |
endstream
endobj
26 0 obj
<>stream
xS**T0T0 BiUD* :
endstream
endobj
27 0 obj
<>stream
x+ |
endstream
endobj
28 0 obj
<>stream
xS**T0T0 BiUD* 8
endstream
endobj
29 0 obj
<>stream
x+ |
endstream
endobj
30 0 obj
<>stream
xS**T0T0 Bih]9D. qaj
endstream
endobj
31 0 obj
<>stream
x+ |
endstream
endobj
32 0 obj
<>stream
xS**T0T0 BiU)D* 9V
endstream
endobj
33 0 obj
<>/XObject<>/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<>>>/Thumb 43 0 R/MediaBox[0 0 612 792]/Rotate 0>>
endobj
44 0 obj
<>/ProcSet[/PDF/Text]/Font<>>>
endobj
35 0 obj
<>stream
/GS1 gs
BT
/F7 1 Tf
8.9663 0 0 8.9663 72 725.7825 Tm
0 0 0 1 k
0 Tc
0 Tw
[(In)-239.4(fact)-240(in)-240.9(FY2007,)-237.2(women)-245.5(constituted)-243.6(61.8%)-237(of)-243.5(participants)]TJ
-1.1128 -1.2203 TD
[(in)-576(NIH-funded)-582.7(clinical)-584.7(research)-580.1(overall.)-576.3(When)-581.1(single-sex)]TJ
0 -1.2266 TD
[(studies)-365(are)-360.5(excluded,)-362.8(participation)-367.2(of)-357.3(men)-361.3(and)-360(women)-365.7(was)]TJ
0 -1.2203 TD
[(nearly)-333.9(equal)-337.5(\(49.8%)-332.3(and)-334.7(46.5%,)-334.8(respectively\).)]TJ
6.7246 0 0 5.9768 241.7952 696.8691 Tm
(4)Tj
8.9663 0 0 8.9663 248.2015 692.9006 Tm
[(Although)-336.9(the)]TJ
-20.7644 -1.2203 TD
[(NIH)-564.8(and,)-558.9(specically,)-565.4(ORWH)-562.7(have)-566.3(done)-565.5(a)-562.2(laudable)-558.5(job)]TJ
0 -1.2266 TD
.0112 Tc
[(in)-4.8(creasing)-492.7(the)-494.5(r)4.2(ate)-494.5(o)2.1(f)-488.8(w)-3.1(omen)-491.7(i)-5(n)-491.7(c)11.2(l)-10.6(ini)-5(c)11.2(a)-6.6(l)-491.8(trials,)-491.2(t)11.2(h)-11.6(e)-1.3(y)-486.4(l)-5(a)11.2(c)-6.6(k)]TJ
0 -1.2203 TD
.0121 Tc
[(the)-455.7(a)-.1(u)4.4(t)-1(hor)5.1(i)-4.1(ty)-447.6(to)-452.2(requ)4.4(ir)5.1(e)-455.7(s)4.5(ubgroup)-450.8(a)-.1(nalysis)-457.1(a)12.1(n)-9.8(d)-452.5(r)5.1(e)-.4(porting)]TJ
T*
0 Tc
[(in)-221.9(publications)-220.5(resulting)-220.9(from)-222.8(the)-218.7(research)-219.7(they)-223.2(fund.)-219.8(Current)]TJ
0 -1.2266 TD
[(wording)-411.5(in)-411.6(the)-408.4(guidelines)-415.9()86.6(strongly)-414.9(encourages)80.4()-412.9(subgroup)]TJ
0 -1.2203 TD
[(analyses)-455.5(in)-455.8(all)-449.2(publication)-459.4(submissions)-458.1(or,)-449(at)-455.2(minimum,)-456.4(a)]TJ
T*
[(brief)-350.5(explanation)-354.6(about)-350(why)-350.9(such)-353.1(information)-353.2(was)-350.2(not)-354.4(pro-)]TJ
T*
(vided.)Tj
6.7246 0 0 5.9768 86.8535 609.2219 Tm
(2)Tj
8.9663 0 0 8.9663 72 594.2549 Tm
[(To)-461(assess)-466.2(the)-459(rate)-468.5(of)-458.5(reporting)-466.2(of)-464.8(sex-specic)-466.8(and)-461.2(race-)]TJ
-1.1128 -1.2203 TD
[(specic)-260.6(results)-255.2(from)-254.4(clinical)-255.9(trials,)-258.6(we)-254.4(conducted)-259(a)-252.4(review)]TJ
6.7246 0 0 5.9768 287.7165 587.2817 Tm
(5)Tj
8.9663 0 0 8.9663 293.3857 583.3132 Tm
(of)Tj
-25.8038 -1.2203 TD
[(randomized)-392.3(controlled)-398.7(trials)-388.4(\(RCTs\))-395.4(published)-394.9(in)-392.6(2004.)-386.7(We)]TJ
0 -1.2266 TD
[(found)-371.4(that)-370.6(federally)-369(funded)-371.5(clinical)-376(trials)-369.5(adhered)-369.8(inconsis-)]TJ
0 -1.2203 TD
[(tently)-486.4(to)-477.5(the)-484.3(standards)-480.1(mandated)-480.6(by)-483.1(the)-478(NIH.)-485.5(The)-480.5(study)]TJ
T*
[(found)-289.2(that)-288.4(women)-283.5(were)-286.7(generally)-291.2(underrepresented)-290.8(in)-285.1(clini-)]TJ
0 -1.2266 TD
[(cal)-204.7(studies)-200.6(that)-206.2(enrolled)-206.4(both)-200.7(men)-203.2(and)-201.9(women,)-204.2(making)-202.5(up,)-201.6(on)]TJ
0 -1.2203 TD
[(average,)-475.5(37%)-474.9(of)-477.5(the)-478(study)-472.1(participants.)-485.2(The)-474.2(ndings)-477.3(sup-)]TJ
T*
[(ported)-457.1(previous)-460.6(research)-459.9(that)-459.1(had)-461.2(included)-453.3(studies)-459.8(begun)]TJ
T*
[(before)-286.4(the)-282(Congressional)-286(mandate)-281.6(in)-278.8(1995.)]TJ
6.7246 0 0 5.9768 229.6062 499.6345 Tm
(68)Tj
8.9663 0 0 8.9663 72 484.6676 Tm
[(Given)-252.9(the)-250.3(continued)-251(emphasis)-254.5(by)-249.1(NIH)-248.7(and)-246.2(others)-255.1(over)-250.7(the)]TJ
-1.1128 -1.2203 TD
[(past)-312.5(5)-315.7(years)-309.3(on)-316(including)-316.3(women)-308.8(and)-315.7(underrepresented)-322.4(mi-)]TJ
T*
[(norities)-445.6(in)-436.9(clinical)-445.6(trials,)-441.9(we)-437.8(were)-438.4(interested)-448.9(in)-436.9(reassessing)]TJ
0 -1.2266 TD
[(compliance)-655.1(in)-658.2(2009.)-652.2(The)-657.5(current)-657.1(analysis)-655.1(evaluated)-659.2(the)]TJ
0 -1.2203 TD
[(inclusion,)-410.7(analysis,)-411.5(and)-404.2(reporting)-415.6(of)-407.9(sex)-408(and)-404.2(race)]TJ
/F3 1 Tf
22.3578 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
(ethnicity)Tj
-22.8573 -1.2203 TD
[(in)-329.4(clinical)-331.7(trials)-337.8(by)-325(examining)-333.5(federally)-331.1(funded)-333.6(studies)-333.4(pub-)]TJ
0 -1.2266 TD
[(lished)-356.1(in)-354.7(2009)-358.5(in)-354.7(the)-357.8(areas)-355(of)-357.3(general)-352.8(internal)-362.2(medicine,)-354.5(on-)]TJ
0 -1.2203 TD
[(cology,)-576.5(cardiology,)-577(infectious)-578.8(disease,)-574.1(and)-575(obstetrics)-576.9(and)]TJ
T*
[(gynecology)-238(\(to)-237.7(assess)-238.6(race)]TJ
/F3 1 Tf
11.3686 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnicity)-239.7(only\))-235.9(and)-233.5(comparing)-240.2(the)]TJ
-11.8681 -1.2266 TD
[(current)-574.9(levels)-571.7(with)-578.1(those)-570.6(from)-576.9(2004.)-570(We)-568(used)-574.6(the)-572.8(same)]TJ
0 -1.2203 TD
[(methodology)-442.3(as)-437.1(in)-436.9(the)-433.7(2004)-434.3(analysis.)-443.1(We)-435.2(also)-437.1(examined)-438.9(a)]TJ
T*
[(sample)-186.5(of)-180.3(studies)-187.9(that)-180.9(did)-186.6(not)-183.7(receive)-181(federal)-184.1(funding)-184(to)-186.6(assess)]TJ
T*
[(if)-282.2(these)-283.2(studies)-282.8(adhered)-281.3(to)-281.5(the)-282(guidelines.)]TJ
/F5 1 Tf
0 -3.0603 TD
[(Materials)-332.7(and)-338.2(Methods)]TJ
/F7 1 Tf
1.1128 -1.8336 TD
[(We)-593.3(located)-590.2(RCTs)-596.7(published)-597.2(in)-588.6(2009)-592.4(by)-590.5(computerized)]TJ
-1.1128 -1.2203 TD
[(search)-345.5(of)-344.7(PubMed,)-340.5(focusing)-345.3(on)-347.6(the)-345.2(areas)-342.4(of)-344.7(general)-340.1(internal)]TJ
T*
[(medicine,)-417.7(oncology,)-418.3(cardiology,)-418.9(infectious)-420.7(disease,)-422.4(and)-416.9(ob-)]TJ
0 -1.2266 TD
[(stetrics)-272.5(and)-271.5(gynecology.)-272.5(We)-270.8(analyzed)-265.7(the)-275.6(same)-270.2(nine)-269.4(journals)]TJ
0 -1.2203 TD
[(as)-203.2(in)-202.9(2004)-200.4(based)-204.2(on)-202.2(both)-200.7(their)-204(impact)-204.1(factor)-205.5(in)-202.9(2003,)-203.3(a)-201.8(rating)-201.7(of)]TJ
T*
[(the)-402.1(frequency)-399.5(with)-401(which)-403.2(articles)-400.3(are)-398.5(cited)-404.5(in)-398.9(a)-397.9(given)-397.7(year)]TJ
T*
[(determined)-340.1(by)-337.6(Journal)-340.5(Citation)-342.6(Reports)]TJ
/F10 1 Tf
6.7246 0 0 5.9768 220.0818 247.5779 Tm
()Tj
/F7 1 Tf
8.9663 0 0 8.9663 228.4157 243.6094 Tm
[(retrieved)-344(from)-336.6(the)]TJ
-18.5577 -1.2266 TD
[(ISI)-382.1(Web)-376.4(of)-382.6(Knowledge)]TJ
/F10 1 Tf
6.7246 0 0 5.9768 153.9212 236.5795 Tm
()Tj
/F7 1 Tf
8.9663 0 0 8.9663 159.2503 232.611 Tm
[(,)-382.3(and)-379(by)-381.9(the)-383.1(number)-380.4(of)-382.6(RCTs)-375.4(pub-)]TJ
-10.8438 -1.2203 TD
[(lished)-191.7(in)-190.3(2004.)-190.7(The)-189.6(2008)-187.7(impact)-191.4(factors)-194.2(have)-186.9(increased)-193.9(for)-193.6(each)]TJ
T*
[(of)-205.6(the)-212.4(nine)-206.2(journals.)-210.1(The)-208.6(journals)-213.5(evaluated)-210.3(were)]TJ
/F11 1 Tf
21.1691 0 TD
[(New)-207.2(England)]TJ
-21.1691 -1.2267 TD
[(Journal)-276(of)-266.7(Medicine,)-275(Journal)-269.7(of)-273.1(the)-272.6(American)-275.4(Medical)-272.6(Association,)]TJ
0 -1.2203 TD
[(Annals)-285.4(of)-292(Internal)-284.2(Medicine,)-294(American)-288.1(Journal)-288.7(of)-285.7(Medicine,)-287.7(Jour-)]TJ
T*
[(nal)-328.1(of)-330(Clinical)-330.3(Oncology,)-329.3(Circulation,)-329.9(Clinical)-330.3(Infectious)-329(Disease,)]TJ
0 -1.2266 TD
[(Obstetrics)-496.1(and)-496.4(Gynecology)]TJ
/F7 1 Tf
11.2738 0 TD
[(,)-496.1(and)-492.8(the)]TJ
/F11 1 Tf
4.7738 0 TD
[(American)-496.7(Journal)-491(of)-494.4(Ob-)]TJ
-16.0476 -1.2203 TD
[(stetrics)-282.5(and)-281.4(Gynecology)]TJ
/F7 1 Tf
9.6235 0 TD
(.)Tj
-8.5106 -1.2203 TD
[(A)-222.7(PubMed)-230.1(search)-225.4(in)-228.2(each)-223.4(journal)-231.2(used)-226.9(limits)-224.9(as)-222.1(indexed)-229.9(by)]TJ
-1.1128 -1.2266 TD
[(the)-187.1(National)-189.7(Library)-187(of)-186.6(Medicine)-188.4(to)-186.6(select)-194.1(all)-183.6(articles)-191.6(described)]TJ
0 -1.2203 TD
[(as)-310.6()80.3(randomized)-311.9(controlled)-316.5(trial)78.9()-311.7(that)-313.7(were)-318.3(in)-310.4(English,)-316.3(based)]TJ
T*
[(on)-366.6(data)-369.2(from)-368.2(humans,)-369.8(and)-366.3(published)-369.6(during)-370.5(2009.)-361.4(In)-365.9(cases)]TJ
T*
[(where)-334.3(an)-331.7(article)-335.7(was)-331.2(published)-337.9(online)-332.7(and)-334.7(also)-329.6(in)-335.7(print,)-334.8(the)]TJ
0 -1.2266 TD
[(date)-198.9(of)-192.9(publication)-200.2(used)-201.6(for)-193.6(selection)-203.8(refers)-199(to)-192.9(the)-199.8(earlier)-197.5(of)-199.3(the)]TJ
0 -1.2203 TD
[(two)-283.1(dates.)]TJ
1.1128 -1.2203 TD
.0104 Tc
[(For)-470.8(e)-2.1(ach)-473.5(a)10.4(r)-8.8(t)-2.7(icle,)-473.1(w)2.5(e)-476.4(d)1.1(et)10.4(e)-8.9(r)-2.9(min)-5.6(e)-2.1(d)-466.8(t)-2.7(he)-476.4(so)-5(urce)-470(of)-476.9(f)10.4(u)-10.4(nd)-5.2(ing)]TJ
-1.1128 -1.2267 TD
.0111 Tc
[(and)-371.3(t)-2(he)-368.2(d)-4.5(a)11.1(t)-7.8(e)-368.2(when)-371.7(study)-372.7(r)4.1(ecrui)-5.1(t)-2(ment)-368.7(began.)-371.2(Lette)11.1(r)-8.5(s)-2.9(,)-364.9(B)-4.5(ri)-5.1(ef)]TJ
27.9978 74.5598 TD
.0117 Tc
[(Communications,)-395.9(and)-396(c)-.2(linical)-396.5(t)-1.4(r)4.7(i)-4.5(als)-394.3(b)1(egun)-396.4(bef)11.7(o)-10.5(re)-392.9(1994)11.7(,)-401.7(a)-.5(s)]TJ
0 -1.2203 TD
.0122 Tc
[(well)-503.5(as)-507.6(s)4.6(t)-.9(udies)-507.6(w)4.3(it)12.2(h)-516.5(n)2.5(o)-509(f)12.2(e)-7.1(d)-3.4(e)12.2(r)-7.4(al)-503.5(su)4.5(pport,)-502.9(w)4.3(ere)-506.2(e)-.3(x)3.7(c).3(luded.)]TJ
0 -1.2266 TD
.0107 Tc
[(S)-6.7(t)10.7(u)-10.1(d)1.4(i)-5.5(e)10.7(s)-281.4(w)-3.6(e)10.7(r)-8.9(e)-273.7(a)-1.5(lso)-270.3(e)-1.8(xcluded)-270.5(w)-3.6(hen)-270.9(a)-1.5(n)-270.9(i)-5.5(ndi)-5.5(v)3.6(id)-4.9(ual)-271(w)-3.6(as)-268.8(n)-5.3(o)1.6(t)-274.3(t)-2.4(he)]TJ
0 -1.2203 TD
.0123 Tc
[(unit)-298(of)-298(randomizat)12.3(i)-10.7(o)3.2(n)-300.9(o)3.2(r)-304.5(a).1(nalysis,)-300.4(w)4.4(h)2.6(ere)-303.7(o)3.2(nly)-295.6(a)-303.4(s)4.7(u)-1.7(bset)-298(of)-304.3(a)]TJ
T*
.0112 Tc
[(trials)-388.5(s)3.6(ubjects)-388.5(w)3.3(ere)-387(a)-1(nalyzed,)-390.1(wh)-4.8(e)11.2(r)-8.4(e)-387(d)-4.4(a)11.2(t)-7.7(a)-386.7(w)-3.1(ere)-387(c)-.7(o)-4.2(m)1(bin)-4.8(e)11.2(d)]TJ
0 -1.2266 TD
.0116 Tc
[(from)-289.5(severa)11.6(l)-294.9(t)-1.5(rials,)-288.5(or)-292.6(where)-285.5(n)-4.4(o)-282(subje)11.6(c)-6.6(t)-1.5(s)-286.9(r)-1.7(esided)-282.3(in)-282.6(the)-291.8(U)3.9(ni-)]TJ
0 -1.2203 TD
.0133 Tc
[(ted)-280.6(S)2.2(ta)13.3(t)-5.6(e).8(s.)]TJ
1.1128 -1.2203 TD
0 Tc
[(For)-324(the)-319.9(analysis)-326.3(of)-319.4(sex-based)-328.1(reporting,)-323.7(studies)-327(published)]TJ
-1.1128 -1.2266 TD
[(in)-449.5(obstetrics)-444.1(and)-448.5(gynecology)-446.6(journals)-441.2(and)-448.5(those)-444.1(that)-446.4(were)]TJ
0 -1.2203 TD
[(specic)-330.1(to)-325.7(only)-330.3(males)-324.3(or)-325.9(females)-324.7(were)-330.9(excluded.)-324.9(Conditions)]TJ
T*
[(that)-307.3(are)-303.6(not)-303.8(exclusive)-302.6(to)-306.7(one)-303.2(sex)-300.5(but)-303.4(may)-298.7(disproportionately)]TJ
T*
[(affect)-335.2(members)-336.5(of)-325.7(one)-334.9(sex)-332.2(\(e.g.,)-329.7(autoimmune)-336.2(diseases\))-332.7(were)]TJ
0 -1.2266 TD
[(not)-209(excluded.)-204.7(Studies)-210.4(based)-204.2(in)-202.9(treatment)-211(facilities)-204.8(for)-206.3(veterans)]TJ
0 -1.2203 TD
[(were)-337.2(not)-341.7(excluded)-334.6(unless)-339.6(they)-337(addressed)-340.4(a)-334.6(condition)-338.3(found)]TJ
T*
[(only)-317.6(in)-316.7(men)-310.7(\(e.g.,)-317(prostate)-316.3(cancer\).)-315.3(We)-315.1(evaluated)-317.7(articles)-311.7(for)]TJ
0 -1.2266 TD
[(the)-484.3(reporting)-478.8(of)-477.5(sex-specic)-479.4(and)-480.1(race)]TJ
/F3 1 Tf
17.1414 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnicity-specic)-488.1(re-)]TJ
-17.6409 -1.2203 TD
[(sults.)-358.7(Obstetrics)-355.9(and)-353.7(gynecology)-358.1(articles)-356(were)-356.2(evaluated)-355.7(for)]TJ
T*
(race)Tj
/F3 1 Tf
1.7957 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnicity-specic)-203.6(results)-204.6(only.)-200.4(We)-201.3(also)-196.8(recorded)-205.3(whether)]TJ
-2.2952 -1.2266 TD
[(sex)-231(and)-227.2(race)]TJ
/F3 1 Tf
5.3239 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnicity)-227(were)-229.8(considered)-231.8(during)-231.4(the)-231.4(analysis)-225.2(of)]TJ
-5.8234 -1.2203 TD
[(outcomes)-467(and)-467.5(whether)-464.6(the)-465.3(authors)-464.8(acknowledged)-467.4(the)-459(po-)]TJ
T*
[(tential)-263.7(impact)-261(of)-256.2(sex,)-259.2(race,)-255.2(or)-262.7(ethnicity)-258.6(on)-259.1(either)-260.8(the)-263(results)-255.2(or)]TJ
T*
[(their)-286.2(generalizability.)]TJ
1.1128 -1.2266 TD
[(The)-290.8(sample)-287.7(distribution)-287.7(across)-289.4(sex)-287.9(and)-284.1(race)]TJ
/F3 1 Tf
19.209 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnicity)-290.3(was)]TJ
-20.8214 -1.2203 TD
[(recorded)-363.3(in)-354.7(terms)-354(of)-357.3(both)-358.8(percent)-359.1(distribution)-357.3(and)-360(absolute)]TJ
T*
[(numbers)-356.4(\(because)-360.2(sample)-357.3(size)-352(drives)-356.9(the)-357.8(ability)-354.5(to)-351(nd)-357.2(sta-)]TJ
0 -1.2266 TD
[(tistical)-289.9(signicance\).)-289.5(Comparisons)-286.3(between)-287.8(subsets)-288.3(of)-281.5(the)-288.3(ar-)]TJ
0 -1.2203 TD
[(ticles)-475.9(were)-463.7(made)-467.9(using)-469.3(Fisher)-468.5(exact)-469.2(test.)-473(Each)-466.8(article)-468.5(was)]TJ
T*
[(examined)-205(in)-196.6(its)-201.3(entirety,)-199.1(including)-202.5(abstract,)-198.3(text,)-201.9(and)-195.6(tables.)-201.8(In)]TJ
0 -1.2266 TD
[(addition)-322.7(to)-325.7(the)-319.9(articles)-318.1(themselves,)-327.1(any)-317.1(published)-325.3(follow-up)]TJ
0 -1.2203 TD
[(articles)-419.2(or)-414.5(comments)-419.6(by)-413.5(either)-418.9(the)-414.7(author\(s\))-415.1(or)-414.5(another)-421.1(re-)]TJ
T*
[(searcher)-289.2(were)-280.3(examined)-280.8(for)-282.1(information)-283.7(relating)-281(to)-281.4(sex,)-278.2(race,)]TJ
0 -1.2266 TD
[(and)-600.3(ethnicity.)-603(The)-600.6(race)]TJ
/F3 1 Tf
10.9766 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnicity)-600.1(portion)-603(of)-603.9(the)-598.1(analysis)]TJ
-11.4761 -1.2203 TD
[(is)-580.2(limited)-574.3(to)-572.3(black)-573.9(and)-575(Hispanic)-574.6(subgroup)-580.4(reporting,)-576.6(as)]TJ
T*
[(other)-336(racial)]TJ
/F3 1 Tf
5.0077 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnic)-332.4(minorities)-326.5(were)-330.9(rarely)-331.2(and)-328.4(inconsistently)]TJ
-5.5073 -1.2203 TD
(reported.)Tj
1.1128 -1.2266 TD
[(We)-384.6(were)-387.8(also)-380.2(interested)-391.9(in)-386.3(whether)-388.7(nonfederally)-384.9(funded)]TJ
-1.1128 -1.2203 TD
[(studies)-263.8(were)-261.4(more)-260.2(or)-256.4(less)-259(compliant)-258(with)-261.9(NIH)-261.3(guidelines.)-260.7(To)]TJ
T*
[(select)-326.9(a)-328.3(sample)-325.6(of)-325.7(nonfederally)-328(funded)-327.3(studies,)-323.6(we)-324(assigned)]TJ
0 -1.2266 TD
[(random)-297.8(numbers)-299.5(generated)-295.7(using)-292.2(Microsoft)-301(Excel)-292.4(to)-300.4(the)-294.6(356)]TJ
0 -1.2203 TD
[(studies)-409.2(that)-408.5(did)-401.6(not)-411.3(acknowledge)-407.5(any)-405.7(federal)-405.4(funding.)-408.2(We)]TJ
T*
[(then)-329.6(sorted)-324.3(the)-326.2(list)-325(and)-328.4(selected)-323.4(the)-326.2(rst)-328(25)-321.5(studies)-327(for)-326.4(anal-)]TJ
0 -1.2266 TD
[(ysis.)-304.3(If)-299.8(a)-303(study)-301.4(was)-299.6(determined)-308.5(to)-300.4(be)-301.5(ineligible)-301.6(\(e.g.,)-304.4(no)-303.3(sub-)]TJ
0 -1.2203 TD
[(jects)-524.4(resided)-523.5(in)-519.1(the)-528.6(United)-517.5(States,)-527.9(only)-519.9(a)-518(portion)-527.2(of)-521.7(trial)]TJ
T*
[(subjects)-362.7(data)-356.6(were)-356.2(analyzed\),)-357.6(that)-357.9(study)-352(was)-356.5(not)-360.7(included,)]TJ
T*
[(and)-284.1(the)-282(next)-284.1(study)-282.4(on)-278(the)-282(list)-280.7(was)-280.7(selected.)]TJ
/F5 1 Tf
0 -3.0603 TD
(Results)Tj
/F7 1 Tf
1.1128 -1.8337 TD
[(The)-341.4(search)-339.2(found)-339.8(512)-340(publications)-340.6(in)-342(the)-338.9(areas)-336.1(of)-338.4(general)]TJ
-1.1128 -1.2203 TD
[(and)-562.3(internal)-564.5(medicine,)-556.8(oncology,)-563.7(cardiac)-554.9(and)-562.3(cardiology,)]TJ
T*
[(obstetrics)-241.8(and)-227.2(gynecology,)-234.6(and)-233.5(infectious)-237.3(disease,)-232.7(all)-234.2(meeting)]TJ
0 -1.2266 TD
[(the)-370.5(search)-364.5(criteria)-368(as)-361.2(of)-363.6(January)-363.4(6,)-362.8(2010.)-367.7(Of)-363.9(these,)-362(426)-365.3(were)]TJ
0 -1.2203 TD
[(eliminated)-191.4(for)-187.3(one)-183.1(or)-186.8(more)-190.6(of)-186.6(the)-187.1(following)-184.1(reasons:)-188.9(no)-189.5(federal)]TJ
T*
[(funding,)-332.3(no)-322.3(support)-331.8(described,)-327.8(funding)-329.4(prior)-325.2(to)-325.7(1994)-320.5(or)-325.9(un-)]TJ
0 -1.2266 TD
[(known)-420.3(date)-413.9(of)-420.6(funding,)-414.5(no)-417.1(subjects)-417.7(residing)-418.1(in)-417.9(the)-414.7(United)]TJ
0 -1.2203 TD
[(States,)-218(full)-211.2(sample)-205.5(of)-211.9(subjects)-215.3(not)-209(described,)-214(or)-205.8(meta-analyses.)]TJ
T*
[(The)-309.8(remaining)-306.8(86)-302.5(studies)-314.4(that)-307.3(were)-305.6(included)-307.8(in)-304.1(this)-305.9(analysis)]TJ
T*
[(represent)-374.4(17%)-367.4(of)-370(all)-360.7(RCTs)-369.1(published)-369.6(in)-367.3(these)-371.7(nine)-370.6(journals,)]TJ
0 -1.2266 TD
[(similar)-363.8(to)-363.6(the)-364.2(14%)-354.7(of)-363.6(studies)-365(that)-364.2(were)-362.5(eligible)-357.9(for)-364.3(the)-364.2(2004)]TJ
0 -1.2203 TD
[(analysis)-199.9(\()]TJ
/F11 1 Tf
4.2111 0 TD
(p)Tj
/F12 1 Tf
.6639 0 TD
()Tj
/F7 1 Tf
.9358 0 TD
[(0.15\).)-200.9(Eighty-one)-202.8(studies)-200.6(\(94%\))-197.6(received)-203(funding)]TJ
-5.8108 -1.2203 TD
[(from)-254.4(the)-250.3(NIH,)-245.3(a)-246.1(signicant)-255.8(increase)-247.8(over)-250.7(the)-250.3(57)-245.6(studies)-251.2(\(83%\))]TJ
0 -1.2267 TD
[(funded)-283(by)-280.7(NIH)-286.6(in)-278.8(2004)-276.3(\()]TJ
/F11 1 Tf
10.9955 0 TD
(p)Tj
/F12 1 Tf
.6639 0 TD
()Tj
/F7 1 Tf
.9421 0 TD
(0.02\).)Tj
/F5 1 Tf
-40.5994 77.2217 TD
(316)Tj
47.0425 0 TD
[(GELLER)-335.4(ET)-338.7(AL.)]TJ
ET
endstream
endobj
45 0 obj
<>/XObject<>/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<>>>/Thumb 49 0 R/MediaBox[0 0 612 792]/Rotate 0>>
endobj
50 0 obj
<>/ProcSet[/PDF/Text]/Font<>>>
endobj
46 0 obj
<>stream
/GS1 gs
BT
/F13 1 Tf
8.9663 0 0 8.9663 59.7543 528.718 Tm
0 0 0 1 k
0 Tc
0 Tw
(Sex)Tj
/F7 1 Tf
1.1128 -1.8336 TD
[(Of)-313.3(the)-313.6(86)-308.8(studies,)-317.3(12)-308.8(were)-311.9(published)-319(in)-310.4(obstetrics)-317.7(and)-309.4(gy-)]TJ
-1.1128 -1.2266 TD
[(necology)-627.5(journals)-618.2(and)-625.5(were)-621.8(excluded)-619.1(from)-621.1(the)-623.4(primary)]TJ
0 -1.2203 TD
[(analysis)-288.4(for)-288.5(reporting)-295.4(of)-287.8(sex)-287.9(differences.)-293(Of)-281.7(the)-294.6(remaining)-287.8(74)]TJ
T*
[(studies,)-298.3(18)-289.9(\(24%\))-292.4(were)-293(sex)-294.2(specic,)-295.1(14)-289.9(enrolling)-290.7(only)-292.3(women)]TJ
T*
[(and)-341(4)-334.6(enrolling)-341.3(only)-336.6(men.)-338.9(Table)-339.2(1)-334.6(shows)-339.2(the)-345.2(distribution)-338.3(of)]TJ
0 -1.2266 TD
[(these)-232.6(studies)-232.2(by)-223.8(journal)-231.2(type.)-224(Among)-230.8(the)-231.4(56)-226.6(studies)-225.9(that)-231.5(were)]TJ
0 -1.2203 TD
[(not)-265.9(sex)-262.6(specic,)-257.2(the)-263(majority)-260.5(of)-262.5(studies)-263.8(\()]TJ
/F11 1 Tf
17.4828 0 TD
(n)Tj
/F12 1 Tf
.7208 0 TD
()Tj
/F7 1 Tf
.9358 0 TD
[(40,)-261.2(71%\))-260.4(enrolled)]TJ
/F12 1 Tf
-19.1395 -1.2203 TD
()Tj
/F7 1 Tf
.7714 0 TD
[(30%)-500.2(women.)-501.4(The)-499.5(percentage)-502(of)-496.4(women)-504.8(in)-493.8(each)-501.6(sample)]TJ
-.7714 -1.2266 TD
[(ranged)-289.1(from)-279.7(1%)-285.7(to)-281.4(78%,)-288.1(the)-282(number)-285.5(of)-281.5(women)-289.8(enrolled)-282.3(ran-)]TJ
0 -1.2203 TD
[(ged)-272.9(from)-273.4(3)-271.4(t)0(o)-268.8(6801,)-272.9(and)-271.5(18)-270.9(studies)-270.1(had)]TJ
/F3 1 Tf
17.2552 0 TD
(>)Tj
/F7 1 Tf
.7714 0 TD
[(300)-270.4(female)-272.8(subjects.)]TJ
-18.0266 -1.2203 TD
[(Comparing)-335.9(2004)-333.2(with)-337.8(2009,)-329.8(there)-333.1(were)-337.2(no)-334.9(signicant)-338(differ-)]TJ
0 -1.2267 TD
[(ences)-395.8(in)-392.6(the)-389.5(median)-392.6(percent)-397(of)-388.9(women)-397.3(enrolled)-389.8(in)-392.6(nonsex-)]TJ
0 -1.2203 TD
[(specic)-317.5(studies)-320.7(\(43%)-317.3(and)-315.7(38%,)-313.4(respectively\);)-321.9(9)-309.3(\(16%\))-317.7(studies)]TJ
T*
(had)Tj
/F12 1 Tf
1.9411 0 TD
()Tj
/F7 1 Tf
.7714 0 TD
[(20%)-266.2(women)-264.5(in)-266.2(2009,)-266.5(compared)-263.3(with)-268.3(7)-258.7(studies)-270.1(\(15%\))-267.2(in)]TJ
-2.7125 -1.2203 TD
(2004.)Tj
1.1128 -1.2266 TD
[(Fourteen)-360.7(of)-363.6(56)-353.1(studies)-365(included)-358.4(in)-354.7(this)-362.8(analysis)-358(\(25%\))-362(re-)]TJ
-1.1128 -1.2203 TD
[(ported)-501.4(at)-499.5(least)-497.9(one)-492.9(outcome)-503.6(by)-495.7(sex,)-493.2(compared)-503.6(with)-495.9(only)]TJ
T*
[(6)-328.3(\(13%\))-330.4(in)-329.4(2004)-333.2(\()]TJ
/F11 1 Tf
7.6381 0 TD
(p)Tj
/F12 1 Tf
.6639 0 TD
()Tj
/F7 1 Tf
.9421 0 TD
[(0.10\).)-327.3(Table)-326.5(2)-334.6(provides)-329.5(a)-328.3(breakdown)-329.6(of)]TJ
-9.2441 -1.2266 TD
[(the)-332.5(inclusion)-331.9(of)-325.7(sex)-325.8(in)-329.4(the)-326.2(modeling)-334.3(and)-322(analysis)-332.7(by)-325(journal)]TJ
0 -1.2203 TD
[(type.)-186.1(Six)-181.2(studies)-187.9(included)-187.7(sex)-180.4(in)-184(the)-187.1(model)-183.8(but)-183.3(did)-180.3(not)-183.7(provide)]TJ
T*
[(sex-specic)-315(data)-306(for)-307.4(any)-304.5(outcome)-307.6(because)-309.2(differences)-309(by)-306(sex)]TJ
0 -1.2267 TD
[(were)-191.8(found)-188(not)-190(to)-186.6(be)-187.7(statistically)-191.6(signicant.)-189.2(Thirty-six)-193.7(studies)]TJ
0 -1.2203 TD
[(\(64%\))-241.9(did)-237.2(not)-240.6(report)-246.2(their)-235.6(ndings)-243.3(by)-236.5(sex,)-240.2(did)-237.2(not)-240.6(include)-241.6(sex)]TJ
T*
[(as)-279(a)-271.4(factor)-281.4(in)-278.8(modeling)-277.3(\(or)-275.8(mention)-276.6()80.3(baseline)-276.6(characteristics)74.4()]TJ
0 -1.2266 TD
[(as)-430.8(a)-429.5(general)-428.7(category)-435.1(of)-426.9(covariate\),)-433.4(and)-429.5(did)-426.8(not)-430.3(provide)-435.6(a)]TJ
0 -1.2203 TD
[(rationale)-323.1(for)-313.8(disregarding)-318.3(sex)-313.2(as)-317(a)-315.7(potential)-318.4(inuence.)-320.2(There)]TJ
28.0042 32.3923 TD
[(was)-394.5(little)-397.1(change)-401.9(from)-393.5(2004,)-393(when)-400.3(67%)-392.7(did)-395.2(not)-398.7(report)-397.9(any)]TJ
0 -1.2266 TD
[(outcomes)-321.6(by)-312.3(sex)-319.5(\()]TJ
/F11 1 Tf
8.1376 0 TD
(p)Tj
/F12 1 Tf
.6639 0 TD
()Tj
/F7 1 Tf
.9358 0 TD
[(0.36\).)-321(Of)-319.7(the)-319.9(9)-315.7(studies)-320.7(with)]TJ
/F3 1 Tf
12.3107 0 TD
(<)Tj
/F7 1 Tf
.7714 0 TD
[(20%)-316.8(wo-)]TJ
-22.8194 -1.2203 TD
[(men)-367.6(subjects,)-363.7(8)-366.2(did)-363.6(not)-373.4(mention)-365.1(any)-367.7(limitations)-367.4(to)-370(general-)]TJ
T*
[(izing)-311.6(the)-313.6(results)-318.4(to)-313.1(both)-314.6(sexes.)-311(Only)-317.9(1)-309.3(study,)-310.7(which)-314.7(enrolled)]TJ
T*
[(98%)-354.7(men)-361.3(from)-361.9(a)-353.6(Veterans)-362.1(Administration)-366(\(VA\))-359.2(population,)]TJ
0 -1.2266 TD
[(acknowledged)-480(that)-484.4(the)-478(ndings)-483.6(may)-475.7(not)-480.9(be)-478.5(applicable)-483.8(to)]TJ
0 -1.2203 TD
(women.)Tj
/F13 1 Tf
0 -2.447 TD
(Race)Tj
/F3 1 Tf
2.3205 0 TD
(=)Tj
/F13 1 Tf
.4995 0 TD
(ethnicity)Tj
/F7 1 Tf
-1.7072 -1.8336 TD
[(None)-189.4(of)-192.9(the)-187.1(86)-188.7(studies)-194.2(addressed)-195(a)-189.2(disease)-191.8(or)-186.8(condition)-199.2(that)]TJ
-1.1128 -1.2203 TD
[(might)-357.1(be)-358.4(considered)-364.6(race)-359.8(specic)-361.7(\(e.g.,)-355(sickle)-366.1(cell)-354(disease)-362.6(in)]TJ
T*
[(African)-299.1(Americans\).)-300.8(Table)-301.2(3)-296.7(provides)-297.9(information)-302.6(on)-303.3(the)-294.6(ex-)]TJ
0 -1.2267 TD
[(tent)-383.6(to)-382.6(which)-384.3(sample)-382.6(size)-383.6(for)-383.3(racial)-385.5(and)-379(ethnic)-389.3(groups)-385(was)]TJ
0 -1.2203 TD
[(reported)-287(in)-291.4(2004)-282.6(and)-284.1(2009.)-285.5(About)-288.6(half)-291.4(of)-287.8(all)-284.8(studies)-289.1(reported)]TJ
T*
[(the)-319.9(percent)-321.1(of)-319.4(subjects)-316.5(who)-317.6(were)-324.6(black)-314.7(\()]TJ
/F11 1 Tf
17.8812 0 TD
(n)Tj
/F12 1 Tf
.7208 0 TD
()Tj
/F7 1 Tf
.9358 0 TD
[(49,)-318.1(57%\))-317.3(or)-319.6(His-)]TJ
-19.5378 -1.2203 TD
[(panic)-247.3(\()]TJ
/F11 1 Tf
2.9528 0 TD
(n)Tj
/F12 1 Tf
.7208 0 TD
()Tj
/F7 1 Tf
.9358 0 TD
[(34,)-248.5(40%\).)-250.6(Eighteen)-251.9(\(21%\))-248.2(studies)-251.2(did)-249.8(not)-253.2(report)-252.5(the)]TJ
-4.6094 -1.2266 TD
[(number)-253.9(of)-256.2(subjects)-259.6(in)-253.5(any)-260.2(racial)]TJ
/F3 1 Tf
13.8851 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnic)-256.5(categories;)-261.3(none)-256(gave)]TJ
-14.3846 -1.2203 TD
[(any)-228.6(indication)-231.1(that)-237.8(recruitment)-234.9(was)-230.1(limited)-232.8(to)-230.9(a)-227.1(single)-231.1(race)-233.3(or)]TJ
T*
[(ethnicity.)-230(More)-236.1(than)-228.1(half)-234.5(of)-230.9(the)-231.4(studies)-232.2(\()]TJ
/F11 1 Tf
17.2995 0 TD
(n)Tj
/F12 1 Tf
.7208 0 TD
()Tj
/F7 1 Tf
.9358 0 TD
[(52,)-229.6(60%\))-235.1(included)]TJ
-18.9561 -1.2266 TD
[(both)-460(white)-464.2(and)-454.8(nonwhite)-467.4(subjects,)-458.5(with)-464.3(the)-459(proportion)-468.7(of)]TJ
0 -1.2203 TD
[(white)-350.4(subjects)-348.1(ranging)-348.1(from)-349.3(10%)-348.4(to)-351(99%.)-345(In)-346.9(15)-346.8(\(17%\))-349.4(of)-344.7(the)]TJ
T*
[(studies,)-317.3(at)-316.1(least)-320.9(90%)-316.8(of)-313.1(subjects)-322.8(were)-318.3(white,)-315.3(without)-323.4(a)-315.7(ratio-)]TJ
0 -1.2267 TD
[(nale)-215(as)-209.5(to)-218.2(why.)-214.7(There)-215.5(has)-212.9(been)-216.3(little)-213.8(change)-218.5(in)-209.3(the)-218.7(reporting)-219.6(of)]TJ
0 -1.2203 TD
[(enrollment)-609.5(by)-609.5(race)]TJ
/F3 1 Tf
8.8774 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnicity)-612.7(since)-608.1(the)-604.4(2004)-611.4(analysis)-604.6(\(all)]TJ
/F11 1 Tf
-9.3769 -1.2203 TD
(p)Tj
/F7 1 Tf
.7777 0 TD
[(values)-284.6(nonsignicant\).)]TJ
.3351 -1.2266 TD
[(Thirteen)-311.5(of)-313.1(the)-307.3(34)-315.2(studies)-308.1(that)-313.7(reported)-318.6(sample)-306.7(counts)-318.4(for)]TJ
-1.1128 -1.2203 TD
[(Hispanic)-397.6(subjects)-398.7(treated)-402.3()80.3(Hispanic)79.2()-393.9(a)0(s)-399.2(a)0(n)-394.9(ethnic)-402(category,)]TJ
ET
59.754 720.113 490.167 .22681 re
f
59.754 614.551 490.167 .22675 re
f
146.721 700.838 74.098 .22675 re
f
231.59 700.838 73.077 .22675 re
f
315.439 700.838 65.254 .22675 re
f
391.464 700.838 74.608 .22675 re
f
476.844 700.838 73.077 .22675 re
f
59.754 683.149 490.167 .22681 re
f
BT
/F9 1 Tf
8.9663 0 0 8.9663 137.3102 725.7825 Tm
(Table)Tj
/F7 1 Tf
3.0666 0 TD
(1.)Tj
/F9 1 Tf
1.2456 0 TD
[(Sex)-332.6(Specicity)-335.1(in)-335.1(Federally)-333.8(Funded)-334.9(Randomized)-338.7(Controlled)-333.6(Trials)]TJ
/F11 1 Tf
-2.82 -2.0423 TD
[(General)-333(medicine)]TJ
/F7 1 Tf
6.7246 0 0 5.9768 213.5054 711.4392 Tm
(a)Tj
/F11 1 Tf
8.9663 0 0 8.9663 248.8818 707.4707 Tm
(Oncology)Tj
/F7 1 Tf
6.7246 0 0 5.9768 283.6346 711.4392 Tm
(b)Tj
/F11 1 Tf
8.9663 0 0 8.9663 319.3511 707.4707 Tm
(Cardiovascular)Tj
/F7 1 Tf
6.7246 0 0 5.9768 373.8329 711.4392 Tm
(c)Tj
/F11 1 Tf
8.9663 0 0 8.9663 395.3763 707.4707 Tm
[(Infectious)-341.7(disease)]TJ
/F7 1 Tf
6.7246 0 0 5.9768 458.0786 711.4392 Tm
(d)Tj
/F11 1 Tf
8.9663 0 0 8.9663 504.1133 707.4707 Tm
(Total)Tj
-49.559 -2.0107 TD
[(Type)-337.8(of)-330(study)-4841.6(2004)-2735.9(2009)-2704.3(2004)-2672.6(2009)-2457.7(2004)-2242.7(2009)-2495.6(2004)-2761.2(2009)-2723.2(2004)-2672.6(2009)]TJ
/F7 1 Tf
0 -2.0929 TD
[(Sex-specic)-343.8(studies)-1724.4(9)-334.6(\(20\))]TJ
6.7246 0 0 5.9768 173.6503 674.6455 Tm
(e)Tj
8.9663 0 0 8.9663 193.8897 670.677 Tm
[(8)-328.3(\(18\))-2231.9(4)-328.3(\(36\))-2200.3(9)-334.6(\(45\))-1732.4(2)-328.3(\(67\))-1764.1(0)-4001.9(0)-4261.2(1)-334.6(\(50\))-1991.7(15)-327.8(\(25\))-1700.8(18)-334.1(\(24\))]TJ
-13.9547 -1.1128 TD
[(Male)-330.5(only)-4756.3(4)-334.6(\(9\))-2757.2(2)-328.3(\(4\))-2731.9(2)-328.3(\(18\))-2200.3(1)-334.6(\(5\))-2232.4(0)-3736.3(0)-4001.9(0)-4261.2(1)-334.6(\(50\))-2491.2(6)-328.3(\(10\))-2200.3(4)-334.6(\(5\))]TJ
0 -1.1065 TD
[(Female)-333.6(only)-3795.2(5)-334.6(\(11\))-2257.2(6)-328.3(\(14\))-2231.9(2)-328.3(\(18\))-2200.3(8)-334.6(\(40\))-1732.4(2)-328.3(\(67\))-1764.1(0)-4001.9(0)-4261.2(0)-4469.8(9)-328.3(\(15\))-1700.8(14)-334.1(\(19\))]TJ
-1.0053 -1.1128 TD
[(Studies)-336.8(including)]TJ
1.0053 -1.1128 TD
[(both)-333.5(sexes)]TJ
8.7193 1.1128 TD
[(36)-334.1(\(80\))-1757.7(36)-327.8(\(82\))-2231.9(7)-328.3(\(64\))-1700.8(11)-334.1(\(55\))-1732.4(1)-328.3(\(33\))-1764.1(8)-334.6(\(100\))-1523.3(2)-334.6(\(100\))-1782.5(1)-334.6(\(50\))-1991.7(46)-327.8(\(75\))-1700.8(56)-334.1(\(76\))]TJ
-7.7203 -2.2257 TD
[(Total)-5472.3(45)-334.1(\(100\))-1257.7(44)-327.8(\(100\))-1232.4(11)-327.8(\(100\))-1200.8(20)-334.1(\(100\))-1232.4(3)-328.3(\(100\))-1264.1(8)-334.6(\(100\))-1523.3(2)-334.6(\(100\))-1782.5(2)-334.6(\(100\))-1491.7(61)-327.8(\(100\))-1200.8(74)-334.1(\(100\))]TJ
5.9774 0 0 5.3127 67.748 606.2739 Tm
(a)Tj
/F11 1 Tf
7.9702 0 0 7.9702 70.7527 602.7589 Tm
[(New)-389(England)-383.4(Journal)-388.2(of)-395.5(Medicin)12.4(e)]TJ
/F7 1 Tf
14.5961 0 TD
[(\(impact)-383.1(factor)-388.1([IF])]TJ
/F12 1 Tf
8.301 0 TD
()Tj
/F7 1 Tf
.9389 0 TD
(50.0\),)Tj
/F11 1 Tf
2.7101 0 TD
(JAMA)Tj
/F7 1 Tf
3.08 0 TD
(\(IF)Tj
/F12 1 Tf
1.3728 0 TD
()Tj
/F7 1 Tf
.9318 0 TD
(31.7\),)Tj
/F11 1 Tf
2.7101 0 TD
[(Annals)-386.5(of)-395.5(Internal)-388.5(Medicine)]TJ
/F7 1 Tf
12.1066 0 TD
(\(IF)Tj
/F12 1 Tf
1.3728 0 TD
()Tj
/F7 1 Tf
.9318 0 TD
(17.4\),)Tj
/F11 1 Tf
2.7101 0 TD
[(American)-387.6(Journal)-388.2(of)]TJ
-53.1422 -1.131 TD
(Medicine)Tj
/F7 1 Tf
4.0331 0 TD
(\(IF)Tj
/F12 1 Tf
1.3728 0 TD
()Tj
/F7 1 Tf
.9318 0 TD
(5.1\).)Tj
5.9774 0 0 5.3127 67.748 588.3589 Tm
(b)Tj
/F11 1 Tf
7.9702 0 0 7.9702 71.0362 584.7872 Tm
[(Journal)-331.3(of)-331.5(Clinical)-330.2(Oncology)]TJ
/F7 1 Tf
11.9927 0 TD
(\(IF)Tj
/F12 1 Tf
1.3657 0 TD
()Tj
/F7 1 Tf
.9389 0 TD
(17.2\).)Tj
5.9774 0 0 5.3127 67.748 579.4014 Tm
(c)Tj
/F11 1 Tf
7.9702 0 0 7.9702 70.3559 575.8298 Tm
(Circulation)Tj
/F7 1 Tf
4.8938 0 TD
(\(IF)Tj
/F12 1 Tf
1.3728 0 TD
()Tj
/F7 1 Tf
.9318 0 TD
(14.6\).)Tj
5.9774 0 0 5.3127 67.748 570.444 Tm
(d)Tj
/F11 1 Tf
7.9702 0 0 7.9702 71.3763 566.8723 Tm
[(Clinical)-323.1(Infectious)-331.3(Disease)]TJ
/F7 1 Tf
11.0396 0 TD
(\(IF)Tj
/F12 1 Tf
1.3728 0 TD
()Tj
/F7 1 Tf
.9318 0 TD
(8.3\).)Tj
5.9774 0 0 5.3127 67.748 561.4298 Tm
(e)Tj
/F11 1 Tf
7.9702 0 0 7.9702 70.526 557.9148 Tm
(n)Tj
/F7 1 Tf
.8891 0 TD
(\(%\).)Tj
ET
59.811 194.797 490.11 .22676 re
f
59.811 69.335 490.11 .22681 re
f
190.318 175.521 69.505 .22676 re
f
266.853 175.521 64.97 .22676 re
f
338.91 175.521 60.491 .22676 re
f
406.488 175.521 66.898 .22676 re
f
480.472 175.521 69.449 .22676 re
f
59.811 157.833 490.11 .22676 re
f
BT
/F9 1 Tf
8.9663 0 0 8.9663 121.8897 200.4661 Tm
(Table)Tj
/F7 1 Tf
3.0603 0 TD
(2.)Tj
/F9 1 Tf
1.2519 0 TD
[(Analysis)-334.1(by)-334.1(Sex)-332.6(in)-335.1(Federally)-333.8(Funded)-334.9(Clinical)-333.9(Trials)-335.4(Including)-335.8(Both)-337.5(Sexes)]TJ
/F11 1 Tf
3.6926 -2.0423 TD
[(General)-333(medicine)-2848.2(Oncology)-2817.7(Cardiovascular)-1368.8(Infectious)-335.4(disease)-3866.8(Total)]TJ
-14.9284 -2.0044 TD
[(Studies)-12329.1(2004)-2268(2009)-2021.4(2004)-2015.1(2009)-2021.4(2004)-1768.5(2009)-1945.5(2004)-2122.5(2009)-2198.4(2004)-2268(2009)]TJ
/F7 1 Tf
0 -2.0992 TD
[(Analysis)-334.6(by)-337.6(sex)-332.2(provided)]TJ
.999 -1.1065 TD
[(or)-332.3(sex)-338.5(included)-333.1(in)-335.7(model)]TJ
14.0558 1.1065 TD
[(5)-334.6(\(14\))]TJ
6.7246 0 0 5.9768 217.0204 149.3858 Tm
(a)Tj
8.9663 0 0 8.9663 233.0645 145.3606 Tm
[(8)-334.6(\(22\))-1289.8(0)-3768(3)-334.6(\(27\))-1289.8(0)-3268.5(3)-334.6(\(37\))-1466.9(1)-334.6(\(50\))-1650.2(0)-3945(6)-334.6(\(13\))-1289.8(14)-334.1(\(25\))]TJ
-19.3228 -2.2193 TD
[(Did)-336.7(not)-335.4(analyze)-332.2(by)-331.3(sex)]TJ
.999 -1.1128 TD
[(but)-335(provided)-337.5(explanation)]TJ
14.0558 1.1128 TD
[(8)-334.6(\(22\))-1789.3(3)-334.6(\(8\))-1789.8(1)-334.6(\(14\))-1789.3(2)-334.6(\(18\))-1289.8(0)-3268.5(1)-334.6(\(13\))-1466.9(0)-3628.9(0)-3945(9)-334.6(\(20\))-1789.3(6)-334.6(\(11\))]TJ
-15.0549 -2.2257 TD
[(Did)-336.7(not)-335.4(include)-336.5(sex)-332.2(in)-335.7(analysis)]TJ
.999 -1.1065 TD
[(or)-332.3(did)-338.3(not)-335.4(provide)]TJ
0 -1.1128 TD
[(an)-331.7(explanation)-342(or)-332.3(both)]TJ
13.5563 2.2193 TD
[(23)-334.1(\(64\))-1289.8(25)-334.1(\(70\))-1289.8(6)-334.6(\(86\))-1789.3(6)-334.6(\(55\))-1289.8(1)-334.6(\(100\))-789.8(4)-334.6(\(50\))-1466.9(1)-334.6(\(50\))-1650.2(1)-334.6(\(100\))-966.9(31)-334.1(\(67\))-1289.8(36)-334.1(\(64\))]TJ
-12.5573 -3.3322 TD
[(Total)-10309.3(36)-334.1(\(100\))-789.8(36)-334.1(\(100\))-789.8(7)-334.6(\(100\))-789.8(11)-334.1(\(100\))-789.8(1)-334.6(\(100\))-789.8(8)-334.6(\(100\))-966.9(2)-334.6(\(100\))-1150.2(1)-334.6(\(100\))-966.9(46)-334.1(\(100\))-789.8(56)-334.1(\(100\))]TJ
5.9774 0 0 5.3127 67.8047 61.0583 Tm
(a)Tj
/F11 1 Tf
7.9702 0 0 7.9702 70.7527 57.4866 Tm
(n)Tj
/F7 1 Tf
.882 0 TD
(\(%\).)Tj
/F5 1 Tf
8.9663 0 0 8.9663 59.7543 749.7069 Tm
[(SUBGROUP)-342(REPORTING)-335.7(IN)-335.1(FEDERALLY)-335.3(FUNDED)-337.3(CLINICAL)-339.5(TRIALS)-19859.7(317)]TJ
ET
endstream
endobj
51 0 obj
<>/XObject<>/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<>>>/Thumb 53 0 R/MediaBox[0 0 612 792]/Rotate 0>>
endobj
54 0 obj
<>/ProcSet[/PDF/Text]/Font<>>>
endobj
52 0 obj
<>stream
/GS1 gs
BT
/F7 1 Tf
8.9663 0 0 8.9663 62.022 560.0692 Tm
0 0 0 1 k
0 Tc
0 Tw
[(separate)-205(from)-203.8(racial)-208.4(description,)-205.5(in)-202.9(accordance)-202.6(with)-205(the)-206.1(Ofce)]TJ
0 -1.2203 TD
[(of)-325.7(Management)-323(and)-322(Budget)-328.3(census)-322.7(categories.)]TJ
6.7246 0 0 5.9768 246.6708 553.0959 Tm
(9)Tj
8.9663 0 0 8.9663 252.9637 549.1274 Tm
[(The)-322.4(remain-)]TJ
-21.2956 -1.2203 TD
[(ing)-384.4(studies)-390.3(considered)-383.5(Hispanic)-391.3(to)-382.6(be)-383.7(a)-385.2(mutually)-384.8(exclusive)]TJ
0 -1.2266 TD
[(race)-246(category)-245.4(\(i.e.,)-246.6(no)-246.4(subject)-245.6(could)-250.2(be)-244.6(classied)-248.3(as)-241.1(both)-245(black)]TJ
0 -1.2203 TD
[(and)-290.4(Hispanic\).)-299.8(The)-290.8(number)-291.9(of)-294.1(studies)-295.4(regarding)-291.5(Hispanic)-296.4(as)]TJ
T*
[(an)-432.9(ethnicity)-435.7(rather)-434.6(than)-436.7(a)-429.5(racial)-429.7(category)-435.1(has)-434.2(substantially)]TJ
T*
[(increased)-314(since)-317.2(2004,)-310.8(when)-311.8(only)-311.3(2)-309.3(o)0(f)-313.1(3)0(3)-308.8(studies)-314.4(reported)-318.6(en-)]TJ
0 -1.2266 TD
[(rollment)-283.7(counts)-286.8(for)-282.1(Hispanic)-277.5(subjects)-284.9(\()]TJ
/F11 1 Tf
17.0972 0 TD
(p)Tj
/F3 1 Tf
.6639 0 TD
(<)Tj
/F7 1 Tf
.9358 0 TD
(0.01\).)Tj
-17.584 -1.2203 TD
[(The)-392(majority)-393.3(of)-388.9(studies)-396.6(in)-386.3(both)-396.7(2004)-390.1(and)-391.6(2009)-390.1(\(83%)-386.8(and)]TJ
-1.1128 -1.2203 TD
[(79%,)-408.2(respectively,)]TJ
/F11 1 Tf
8.3905 0 TD
(p)Tj
/F12 1 Tf
.6702 0 TD
()Tj
/F7 1 Tf
.9358 0 TD
[(0.37\))-412.9(did)-407.9(not)-417.6(report)-410.6(any)-412(outcome)-415.1(by)]TJ
-9.9965 -1.2266 TD
[(race)-246(or)-243.7(include)-241.6(it)-244.3(in)-240.9(the)-244(model.)-243.6(Table)-244.3(4)-239.8(shows)-244.4(the)-244(distribution)]TJ
0 -1.2203 TD
[(of)-452.2(the)-452.7(inclusion)-458.4(of)-452.2(race)]TJ
/F3 1 Tf
10.6668 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnicity)-454.7(in)-449.5(the)-459(model)-449.4(or)-452.4(analysis)]TJ
-11.1663 -1.2203 TD
[(by)-356.6(journal)-364(type.)-363.1(Twelve)-356.5(studies)-365(did)-357.3(report)-366.3(at)-354.1(least)-365.1(one)-360.1(out-)]TJ
0 -1.2266 TD
[(come)-448.4(by)-451.4(racial)]TJ
/F3 1 Tf
6.7086 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnic)-452.6(subgroup,)-450.6(and)-448.5(3)-448.4(studies)-453.5(found)-453.6(that)]TJ
-7.2081 -1.2203 TD
(race)Tj
/F3 1 Tf
1.7894 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnicity)-467.3(was)-457.7(a)-461.1(key)-457.7(predictor)-467(of)-458.5(the)-459(outcomes)-467(under)]TJ
-2.2889 -1.2203 TD
[(study.)-190.5(Only)-191.4(1)-182.9(study,)-190.5(which)-194.6(enrolled)-187.4(97%)-190.3(white)-192.3(subjects,)-193(noted)]TJ
0 -1.2266 TD
[(that)-269.4(the)-269.3(lack)-266(of)-268.8(racial)]TJ
/F3 1 Tf
9.1682 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnic)-275.5(diversity)-270.5(in)-266.2(their)-267.2(sample)-268.7(limited)]TJ
-9.6677 -1.2203 TD
[(the)-667.7(applicability)-666.6(of)-667.1(their)-665.6(ndings)-667(to)-667.1(other)-664.8(racial)]TJ
/F3 1 Tf
23.5149 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
(ethnic)Tj
-24.0144 -1.2203 TD
[(groups.)-343.6(In)-346.9(81)-340.5(articles)-343.4(\(94%\),)-345.9(the)-345.2(ndings)-344.5(were)-343.6(deemed)-344.7(gen-)]TJ
T*
[(eralizable)-279.6(without)-285.5(regard)-280.1(to)-281.4(race)-283.9(or)-281.7(ethnicity.)]TJ
1.1128 -1.2266 TD
.0111 Tc
[(Of)-356.1(12)-355.1(eli)-5.1(g).4(ible)-355.5(stud)-4.5(ies)-356.9(i)1.2(n)-359(o)2(bstet)11.1(r)-9(ics)-356.9(a)-1.1(nd)-358.6(gyneco)-4.3(l)1.2(ogy)-360(j)-.2(our-)]TJ
-1.1128 -1.2203 TD
[(nals,)-225.7(9)-222.3(reported)-219.4(the)-222.6(n)-4.8(um)-5.3(be)11.2(r)-229.7(o)-4.2(f)-223.2(b).5(lack)-220.8(women)-226.1(e)11.2(n)-11.1(r)4.2(o)-4.2(lled)-4.4(,)-219.3(which)]TJ
T*
[(ranged)-295.5(f)11(r)-9.1(om)-296.4(1%)-294.1(t)11(o)-302.1(57%,)-295.4(a)-1.2(nd)-295.5(7)-292(r)-2.3(epo)-4.4(r)4(ted)-295.5(t)11(h)-11.8(e)-292.4(number)-293.2(o)-4.4(f)-293(His-)]TJ
27.9978 26.885 TD
.0113 Tc
[(pani)-4.9(c)-228.3(w)3.4(o)-4.1(m)1.1(en,)-231.9(w)3.4(h)-4.7(i)1.5(ch)-226(ranged)-232(fro)-4.1(m)-226.5(4%)-230.6(to)-225.4(52%.)-225.6(T)-4.3(here)-235.2(were)-228.9(no)]TJ
0 -1.2203 TD
.0089 Tc
[(d)-6.8(i)-1(f)-4.2(f)-4.2(e)-3.6(re)-3.6(nce)-3.6(s)-485.6(i)-7.3(n)-487.7(re)-3.6(p)-5.1(o)-.2(r)-4.4(t)-4.2(ing)-488.7(o)-.2(f)-491.1(s)1.3(a)-3.3(m)-1.3(p)-5.1(l)-1(e)-484.2(s)-5.1(iz)-3.3(e)-490.5(f)8.9(o)-13.3(r)-485(r)-4.5(a)8.9(c)-8.9(e)]TJ
/F3 1 Tf
22.2693 0 TD
0 Tc
(=)Tj
/F7 1 Tf
.4995 0 TD
.0114 Tc
[(ethni)-4.8(city)]TJ
-22.7688 -1.2203 TD
.0118 Tc
[(be)11.8(t)-7.5(w)-2.5(een)-522.7(t)11.8(h)-11(ese)-525.5(j).5(ournals)-520.6(a)-.4(nd)-522.3(the)-519.2(s)-2.2(ev)4.7(en)-522.7(medicine)-525.5(journals)]TJ
0 -1.2266 TD
0 Tc
(\()Tj
/F11 1 Tf
.5058 0 TD
(p)Tj
/F12 1 Tf
.6766 0 TD
()Tj
/F7 1 Tf
.9358 0 TD
.0125 Tc
[(0.15)-252.6(for)-253.8(b)1.8(lacks)-254.4(a).3(nd)-256.1(0)12.5(.)-8.9(1)12.5(3)-264.7(for)-253.8(H)-.1(is)4.9(panics\).)-256(Only)-257.5(1)-258.9(o)3.4(f)-253.5(t)-.6(he)-253(12)]TJ
-2.1182 -1.2203 TD
.012 Tc
[(obst)12(e)-7.3(t)-1.1(rics)-204.3(and)-206(gynecology)-207.4(s)4.4(tudies)-204.3(repor)5(t)-1.1(ed)-206(r)5(e)-.5(sults)-204.3(b)1.3(y)-201.1(r)-1.4(ac)12(e)-214.8(o)2.9(r)]TJ
T*
.0116 Tc
[(eth)-4.4(n)1.9(icity.)-655.2(The)-658.5(p)3.9(roportion)-655.7(o)2.5(f)-659.1(o)2.5(bstetri)-4.6(c)11.6(s)-665.5(a)-.6(nd)-655.3(gyn)-4.4(ecology)]TJ
T*
.0122 Tc
[(studies)-254.7(t)-.9(hat)-260.2(d)2.9(id)-256.4(not)-253.8(r)-1.1(ep)4.5(or)5.2(t)-260.2(r)5.2(esults)-254.7(by)-257.8(r)5.2(a)0(ce)]TJ
/F3 1 Tf
18.4376 0 TD
0 Tc
(=)Tj
/F7 1 Tf
.4995 0 TD
.0111 Tc
[(et)11.1(h)-11.7(n)1.4(icity,)-257.4(in)-4.9(clude)]TJ
-18.9371 -1.2266 TD
.0107 Tc
[(i)-5.5(t)-286.9(in)-283.5(a)-286(m).5(o)-4.7(d)1.4(el,)-289.4(o)1.6(r)-287.2(p)3(ro)-4.7(vi)-5.5(de)-286.4(an)-283.5(explanatio)-4.7(n)-283.5(d)-4.9(id)-283.2(n)-5.3(o)1.6(t)-286.9(d)1.4(iffer)-287.2(f)-2.4(ro)-4.7(m)]TJ
0 -1.2203 TD
.012 Tc
[(the)-639.2(o)2.9(ther)-640(seven)-636.3(j).7(ournals)-640.6(i)2.1(n)-636.3(2004)-638.8(\()]TJ
/F11 1 Tf
17.1541 0 TD
0 Tc
(p)Tj
/F12 1 Tf
.6765 0 TD
()Tj
/F7 1 Tf
.9358 0 TD
.0111 Tc
[(0.19\))-640.6(or)-640.9(in)-637.2(2009)]TJ
-18.7664 -1.2203 TD
0 Tc
(\()Tj
/F11 1 Tf
.5058 0 TD
(p)Tj
/F12 1 Tf
.6766 0 TD
()Tj
/F7 1 Tf
.9358 0 TD
.0118 Tc
(0.28\).)Tj
/F13 1 Tf
-2.1182 -3.0603 TD
0 Tc
[(Phase)-339.5(III)-333.1(studies)]TJ
/F7 1 Tf
1.1128 -1.8336 TD
[(Of)-300.7(the)-307.3(86)-296.2(studies)-308.1(discussed)-304.9(here,)-304(12)-296.2(were)-305.6(described)-305.9(in)-297.8(the)]TJ
-1.1128 -1.2203 TD
[(body)-210.6(of)-211.9(the)-212.4(article)-215.6(as)-209.5(phase)-207.8(III)-215(drug)-211.8(studies)-213.2(for)-206.3(which)-213.6(the)-212.4(NIH)]TJ
T*
[(requires)-353.3(sample)-344.6(sizes)-353.3(adequate)-343.2(to)-351(allow)-346.1(subgroup)-346.5(compari-)]TJ
T*
[(sons.)-188.7(One)-183.4(third)-181.8(\()]TJ
/F11 1 Tf
7.0564 0 TD
(n)Tj
/F12 1 Tf
.7208 0 TD
()Tj
/F7 1 Tf
.9358 0 TD
[(4\))-183.3(of)-186.6(the)-180.8(phase)-188.8(III)-183.4(studies)-181.6(were)-185.5(sex)-186.7(specic)]TJ
-8.713 -1.2266 TD
[(and)-353.7(enrolled)-351.8(only)-349.2(women,)-349.6(with)-350.5(3)-353.6(studies)-352.3(focused)-349.5(on)-353.9(breast)]TJ
0 -1.2203 TD
[(cancer)-280.3(and)-271.5(1)-271.4(focused)-273.7(on)-278(cervical)-272(cancer.)-276.9(Of)-269.1(the)-275.6(8)-271.4(studies)-276.4(that)]TJ
T*
[(were)-242.4(not)-246.9(sex)-237.3(specic,)-244.5(4)-239.8(\(50%\))-241.9(provided)-242.6(results)-242.5(for)-244.2(at)-240.3(least)-245(one)]TJ
0 -1.2266 TD
[(outcome)-288.7(by)-287(sex.)-284.5(Women)-280.9(constituted)-294.2(15%50%)-279(of)-287.8(the)-282(sample)]TJ
0 -1.2203 TD
[(populations)-261.6(for)-256.9(these)-257.9(studies.)-260.4(Among)-256.1(all)-259.5(12)-251.9(phase)-258.4(III)-259.3(studies,)]TJ
T*
[(3)-195.5(\(25%\))-185(reported)-198.5(race)]TJ
/F3 1 Tf
9.1113 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnicity-specic)-197.2(results.)-194.9(In)-188.9(2004,)-190.7(only)-191.2(4)]TJ
ET
62.022 720.113 490.167 .28345 re
f
62.022 604.63 490.167 .22681 re
f
172.063 700.838 116.617 .28345 re
f
303.817 700.838 116.617 .28345 re
f
435.628 700.838 116.561 .28345 re
f
62.022 683.149 490.167 .28345 re
f
BT
/F9 1 Tf
8.9663 0 0 8.9663 183.8551 725.7825 Tm
(Table)Tj
/F7 1 Tf
3.0603 0 TD
(3.)Tj
/F9 1 Tf
1.2519 0 TD
[(Reporting)-333.4(of)-336.4(Subjects)-333.6(by)-334.1(Racial)]TJ
/F3 1 Tf
15.5291 0 TD
(=)Tj
/F9 1 Tf
.4995 0 TD
[(Ethnic)-330(Groups)]TJ
/F11 1 Tf
-16.3637 -2.0423 TD
[(White)-12413.2(Black)-11826(Hispanic)]TJ
-17.565 -2.0044 TD
[(Studies)-9306.8(2004)]TJ
/F7 1 Tf
14.6059 0 TD
(\(n)Tj
/F12 1 Tf
1.0623 0 TD
()Tj
/F11 1 Tf
.9358 0 TD
(69)Tj
/F7 1 Tf
1.0053 0 TD
(\))Tj
/F11 1 Tf
2.0107 0 TD
(2009)Tj
/F7 1 Tf
2.3332 0 TD
(\(n)Tj
/F12 1 Tf
1.0622 0 TD
()Tj
/F11 1 Tf
.9421 0 TD
(86)Tj
/F7 1 Tf
.999 0 TD
(\))Tj
/F11 1 Tf
2.0107 0 TD
(2004)Tj
/F7 1 Tf
2.3332 0 TD
(\(n)Tj
/F12 1 Tf
1.0623 0 TD
()Tj
/F11 1 Tf
.9421 0 TD
(69)Tj
/F7 1 Tf
.999 0 TD
(\))Tj
/F11 1 Tf
2.0107 0 TD
(2009)Tj
/F7 1 Tf
2.3332 0 TD
(\(n)Tj
/F12 1 Tf
1.0623 0 TD
()Tj
/F11 1 Tf
.9421 0 TD
(86)Tj
/F7 1 Tf
.999 0 TD
(\))Tj
/F11 1 Tf
2.017 0 TD
(2004)Tj
/F7 1 Tf
2.3268 0 TD
(\(n)Tj
/F12 1 Tf
1.0623 0 TD
()Tj
/F11 1 Tf
.9421 0 TD
(69)Tj
/F7 1 Tf
.999 0 TD
(\))Tj
/F11 1 Tf
2.017 0 TD
(2009)Tj
/F7 1 Tf
2.3332 0 TD
(\(n)Tj
/F12 1 Tf
1.0622 0 TD
()Tj
/F11 1 Tf
.9358 0 TD
(86)Tj
/F7 1 Tf
.999 0 TD
(\))Tj
-54.3454 -2.0929 TD
[(Studies)-336.8(with)-337.8(unknown)]TJ
.999 -1.1128 TD
[(number)-336.1(of)-338.4(subjects)]TJ
T*
[(in)-335.7(given)-334.4(racial)]TJ
/F3 1 Tf
6.3419 0 TD
(=)Tj
/F7 1 Tf
-6.3419 -1.1128 TD
[(ethnic)-338.7(group)]TJ
12.4245 3.3385 TD
[(17)-334.1(\(25\))]TJ
6.7246 0 0 5.9768 209.0834 674.7021 Tm
(a)Tj
8.9663 0 0 8.9663 249.959 670.7337 Tm
[(23)-334.1(\(27\))-4369.1(23)-334.1(\(33\))-4369.1(37)-334.1(\(43\))-4369.1(36)-334.1(\(52\))-4369.1(52)-334.1(\(61\))]TJ
-20.9604 -4.445 TD
[(Studies)-336.8(reporting)]TJ
/F3 1 Tf
7.9795 0 TD
(<)Tj
/F7 1 Tf
.7714 0 TD
(10%)Tj
-7.7519 -1.1128 TD
[(of)-338.4(subjects)-335.5(in)-335.7(given)]TJ
T*
(racial)Tj
/F3 1 Tf
2.3837 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnic)-338.7(group)]TJ
10.0661 2.2257 TD
[(0)-6992.7(0)-6866.2(9)-334.6(\(14\))-4369.1(14)-334.1(\(16\))-4369.1(19)-334.1(\(28\))-4369.1(19)-334.1(\(22\))]TJ
5.9774 0 0 5.3127 70.0157 596.3526 Tm
(a)Tj
/F11 1 Tf
7.9702 0 0 7.9702 72.9637 592.7809 Tm
(n)Tj
/F7 1 Tf
.8891 0 TD
(\(%\).)Tj
ET
62.079 273.316 490.167 .22678 re
f
62.079 78.123 490.167 .22678 re
f
155.509 244.063 66.444 .28348 re
f
226.035 244.063 66.501 .28348 re
f
296.617 244.063 57.487 .28348 re
f
358.186 244.063 57.487 .28348 re
f
419.754 244.063 61.965 .28348 re
f
485.801 244.063 66.444 .28348 re
f
62.079 226.375 490.167 .28348 re
f
BT
/F9 1 Tf
8.9663 0 0 8.9663 129.9401 278.9858 Tm
(Table)Tj
/F7 1 Tf
3.0603 0 TD
(4.)Tj
/F9 1 Tf
1.2519 0 TD
[(Analysis)-334.1(by)-334.1(Racial)]TJ
/F3 1 Tf
9.2378 0 TD
(=)Tj
/F9 1 Tf
.4995 0 TD
[(Ethnic)-330(Groups)-338.4(in)-335.1(Federally)-333.8(Funded)-334.9(Clinical)-333.9(Trials)]TJ
/F11 1 Tf
-9.0607 -2.0423 TD
(General)Tj
-.2023 -1.1128 TD
[(medicine)-4163.3(Oncology)-2394(Cardiovascular)]TJ
21.9215 1.1128 TD
(Infectious)Tj
.5754 -1.1128 TD
(disease)Tj
6.4494 1.1128 TD
(Obstetrics)Tj
-1.1128 -1.1128 TD
[(and)-332(gynecology)-3429.3(Total)]TJ
-40.1884 -2.0044 TD
[(Studies)-8194(2004)-1932.9(2009)-1932.9(2004)-1932.9(2009)-1686.3(2004)-1433.3(2009)-1433.3(2004)-1433.3(2009)-1433.3(2004)-1686.3(2009)-1932.9(2004)-1932.9(2009)]TJ
/F7 1 Tf
0 -2.0929 TD
[(Analysis)-334.6(by)-337.6(race)]TJ
/F3 1 Tf
7.3535 0 TD
(=)Tj
/F7 1 Tf
-6.3545 -1.1128 TD
[(ethnicity)-340.8(provided)]TJ
T*
[(or)-332.3(variable)-340.6(included)]TJ
0 -1.1065 TD
[(in)-335.7(model)]TJ
9.9206 3.3322 TD
[(4)-334.6(\(9\))]TJ
6.7246 0 0 5.9768 177.7322 217.9275 Tm
(a)Tj
8.9663 0 0 8.9663 195.2503 213.959 Tm
[(5)-334.6(\(11\))-1454.2(1)-334.6(\(9\))-1960.6(4)-328.3(\(20\))-2029.6(0)-1864.8(2)-328.3(\(25\))-2029.6(0)-2933.3(0)-1864.8(1)-328.3(\(13\))-1460.6(1)-328.3(\(8\))-1960.6(6)-334.6(\(9\))-1454.7(12)-334.1(\(14\))]TJ
-14.8525 -4.445 TD
[(Did)-336.7(not)-335.4(analyze)]TJ
.999 -1.1128 TD
[(by)-331.3(race)]TJ
/F3 1 Tf
3.231 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
(ethnicity)Tj
-3.7305 -1.1128 TD
[(but)-335(provided)]TJ
0 -1.1065 TD
(explanation)Tj
9.9206 3.3322 TD
[(5)-334.6(\(11\))-1454.2(4)-334.6(\(9\))-2782.5(0)-2610.9(1)-328.3(\(5\))]TJ
16.3068 0 TD
2.9333 Tc
[(0000)1068.5(1)]TJ
13.4931 0 TD
0 Tc
[(\(13\))-1460.6(1)-328.3(\(8\))-1960.6(6)-334.6(\(9\))-1954.2(6)-334.6(\(7\))]TJ
-40.7195 -4.445 TD
[(Did)-336.7(not)-335.4(include)-336.5(race)]TJ
/F3 1 Tf
9.124 0 TD
(=)Tj
/F7 1 Tf
-8.1249 -1.1128 TD
[(ethnicity)-340.8(in)-329.4(analysis)]TJ
T*
[(or)-332.3(did)-338.3(not)-335.4(provide)]TJ
0 -1.1065 TD
[(an)-331.7(explanation)]TJ
0 -1.1128 TD
[(or)-332.3(both)]TJ
9.4211 4.445 TD
[(36)-334.1(\(80\))-954.7(35)-334.1(\(80\))-954.7(10)-334.1(\(91\))-954.7(15)-334.1(\(75\))-961(3)-328.3(\(100\))-461.1(6)-328.3(\(75\))-961(2)-328.3(\(100\))-461.1(2)-328.3(\(100\))-461.1(6)-328.3(\(75\))-961(10)-327.8(\(83\))-961(57)-334.1(\(83\))-954.7(68)-334.1(\(79\))]TJ
-8.4221 -5.5578 TD
[(Total)-6174.1(45)-334.1(\(100\))-454.7(44)-334.1(\(100\))-454.7(11)-334.1(\(100\))-454.7(20)-334.1(\(100\))-461(3)-328.3(\(100\))-461.1(8)-328.3(\(100\))-461(2)-328.3(\(100\))-461.1(2)-328.3(\(100\))-461.1(8)-328.3(\(100\))-461(12)-327.8(\(100\))-461.1(69)-334.1(\(100\))-454.7(86)-334.1(\(100\))]TJ
7.9702 0 0 7.9702 70.0724 66.274 Tm
[(Percenta)10.6(ges)-335.2(may)-327.9(not)-329.1(total)-331.6(to)-332(100%)-327.3(because)-328.9(of)-332(rounding.)]TJ
5.9774 0 0 5.3127 70.0724 60.8882 Tm
(a)Tj
/F11 1 Tf
7.9702 0 0 7.9702 73.0204 57.3165 Tm
(n)Tj
/F7 1 Tf
.882 0 TD
(\(%\).)Tj
/F5 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(318)Tj
47.0425 0 TD
[(GELLER)-335.4(ET)-338.7(AL.)]TJ
ET
endstream
endobj
55 0 obj
<>/XObject<>/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<>>>/Thumb 57 0 R/MediaBox[0 0 612 792]/Rotate 0>>
endobj
58 0 obj
<>/ProcSet[/PDF/Text]/Font<>>>
endobj
56 0 obj
<>stream
/GS1 gs
BT
/F7 1 Tf
8.9663 0 0 8.9663 59.7543 725.7825 Tm
0 0 0 1 k
0 Tc
0 Tw
[(studies)-194.2(were)-185.5(designated)-189.1(to)-186.6(be)-187.7(phase)-188.8(III)-189.7(drug)-186.5(studies,)-184.5(and)-189.3(none)]TJ
0 -1.2203 TD
[(reported)-287(outcomes)-283.6(by)-280.7(sex)-281.6(or)-281.7(race)]TJ
/F3 1 Tf
14.587 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
(ethnicity.)Tj
/F13 1 Tf
-15.0865 -2.447 TD
[(Nonfederally)-338.3(funded)-335.4(studies)]TJ
/F7 1 Tf
1.1128 -1.8336 TD
[(We)-283.5(reviewed)-287.5(25)-277.2(articles)-286.4(randomly)-286.8(selected)-285.5(from)-286(356)-276.7(stud-)]TJ
-1.1128 -1.2203 TD
[(ies)-289.3(that)-288.4(did)-287.7(not)-291.2(acknowledge)-287.3(any)-285.5(federal)-291.5(funding)-291.4(support)-287.5(to)]TJ
0 -1.2266 TD
[(determine)-375.1(if)-370.7(privately)-374.6(funded)-371.5(clinical)-376(trials)-369.5(reported)-375.5(results)]TJ
0 -1.2203 TD
[(for)-282.1(sex)-281.6(or)-281.7(racial)-284.3(differences)-283.7(at)-278.2(the)-282(same)-282.8(rates)-280.1(as)-285.4(those)-279.7(studies)]TJ
T*
[(with)-413.7(federal)-411.7(funding.)-408.2(Aside)-413.8(from)-406.2(funding)-411.6(source,)-412.9(all)-411.2(other)]TJ
T*
[(exclusion)-478.8(criteria)-481.8(\(e.g.,)-475.1(all)-468.1(participants)-482.3(resided)-479.2(outside)-473.9(the)]TJ
0 -1.2266 TD
[(United)-188.7(States,)-192.8(only)-184.8(a)-182.9(portion)-192(of)-186.6(a)-182.9(trials)-188(subjects)-190(was)-185.8(analyzed\))]TJ
0 -1.2203 TD
[(were)-318.3(the)-319.9(same.)-317.4(In)-315.3(terms)-316.1(of)-319.4(the)-319.9(analysis)-313.7(and)-322(reporting)-320.7(of)-313.1(sex)]TJ
T*
(and)Tj
/F3 1 Tf
1.6819 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(or)-237.4(racial)]TJ
/F3 1 Tf
3.5472 0 TD
(=)Tj
/F7 1 Tf
.5058 0 TD
[(ethnic)-243.9(differences,)-242.4(nonfederally)-245.8(funded)-245.1(studies)]TJ
-6.2344 -1.2266 TD
[(did)-300.4(not)-291.2(differ)-298.9(signicantly)-301.7(from)-298.7(the)-294.6(federally)-299.5(funded)-295.6(studies)]TJ
0 -1.2203 TD
[(which)-466.5(are)-455.4(bound)-463.9(by)-457.8(the)-459(guidelines)-466.5(of)-458.5(the)-459(NIH)-463.6(and)-454.8(other)]TJ
T*
[(federal)-241(funding)-234.5(agencies.)-235.5(Of)-237.5(the)-237.7(25)-233(studies,)-235.1(10)-233(\(40%\))-235.5(were)-236.1(sex)]TJ
0 -1.2266 TD
[(specic)-399.7(\(2)-392(enrolled)-402.4(men)-392.9(only)-393.5(and)-397.9(8)-391.5(enrolled)-396.1(only)-399.8(women\).)]TJ
0 -1.2203 TD
[(Studies)-298.9(including)-297.3(both)-295.6(men)-298(and)-290.4(women)-296.1(enrolled)-294.9(women)-296.1(as,)]TJ
T*
[(on)-271.7(average,)-273.2(40%)-266.2(of)-268.8(their)-273.5(total)-272.3(sample.)-265.3(Three)-272.4(of)-268.8(the)-269.3(15)-270.9(studies)]TJ
0 -1.2266 TD
[(that)-244.1(enrolled)-238(both)-245(sexes)-238.5(reported)-242.7(at)-240.3(least)-238.7(one)-240(outcome)-238.1(by)-242.8(sex.)]TJ
0 -1.2203 TD
[(One)-347.8(additional)-344.7(study,)-348.6(a)-340.9(phase)-346.9(II)-339.3(drug)-344.6(study,)-348.6(noted)-344.6(that)-345.3(the)]TJ
T*
[(subsequent)-321.3(phase)-315.3(III)-309.8(study)-314.1(would)-315.8(be)-307.8(designed)-315.6(to)-313.1(detect)-319.2(dif-)]TJ
T*
[(ferences)-592.9(between)-585(the)-585.5(sexes.)-589.2(Although)-589.8(nearly)-586.8(half)-582.3(of)-584.9(the)]TJ
0 -1.2266 TD
[(studies)-219.5(\()]TJ
/F11 1 Tf
3.642 0 TD
(n)Tj
/F12 1 Tf
.7145 0 TD
()Tj
/F7 1 Tf
.9421 0 TD
[(12,)-210.6(48%\))-209.8(reported)-217.4(the)-218.7(racial)]TJ
/F3 1 Tf
11.7733 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnic)-212.3(distribution)-218.2(of)]TJ
-17.5714 -1.2203 TD
[(their)-223(subjects,)-224.6(none)-218.1(of)-218.2(the)-225.1(25)-214(studies)-225.9(reported)-217.5(any)-222.3(outcome)-219.1(by)]TJ
T*
(race)Tj
/F3 1 Tf
1.7957 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
(ethnicity.)Tj
/F5 1 Tf
-2.2952 -2.447 TD
(Discussion)Tj
/F7 1 Tf
1.1128 -1.8336 TD
[(This)-510.7(research)-510.5(was)-508.3(undertaken)-509.2(to)-509.1(examine)-511.8(studies)-510.4(pub-)]TJ
-1.1128 -1.2203 TD
[(lished)-425.7(in)-424.2(nine)-421.2(high-impact)-427.9(journals)-422.2(in)-424.2(2009)-421.7(for)-421.3(compliance)]TJ
0 -1.2266 TD
[(with)-306.2(the)-300.9(NIH)-305.6(inclusion)-306.6(and)-303.1(reporting)-301.8(guidelines)-308.4(for)-301.1(sex)-306.9(and)]TJ
0 -1.2203 TD
(race)Tj
/F3 1 Tf
1.7957 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnicity)-593.8(and)-587.6(to)-591.3(compare)-589.1(the)-591.8(results)-590.3(with)-590.7(previous)]TJ
-2.2952 -1.2203 TD
[(ndings)-350.8(from)-342.9(2004.)-342.4(We)-346.7(found)-346.1(very)-347.2(little)-346.6(improvement)-349.3(over)]TJ
T*
[(the)-294.6(last)-289.4(5)-284(years.)-293.3(The)-290.8(median)-285.1(enrollment)-293.4(of)-287.8(women)-289.8(in)-291.4(studies)]TJ
0 -1.2266 TD
[(that)-225.1(included)-225.6(both)-226(sexes)-225.9(remained)-222.5(low,)-225.8(at)-221.3(37%.)-224.9(Our)-220.1(nding)-229.4(is)]TJ
0 -1.2203 TD
[(reinforced)-304.5(by)-293.4(two)-295.7(reviews)-298.6(of)-300.4(published)-293.7(cardiovascular)-299.3(stud-)]TJ
T*
[(ies)-327.2(that)-326.3(also)-329.6(found)-327.1(that)-326.3(inclusion)-325.6(of)-332(women)-321.4(and)-328.4(sex-specic)]TJ
0 -1.2266 TD
[(analysis)-282.1(and)-284.1(reporting)-282.8(remain)-282.8(low.)]TJ
6.7246 0 0 5.9768 197.9149 313.3416 Tm
(10,11)Tj
8.9663 0 0 8.9663 69.7323 298.3748 Tm
[(One)-385.7(fth)-380.4(of)-388.9(the)-383.1(studies)-383.9(we)-380.9(reviewed)-388.7(failed)-383(to)-382.6(report)-385.3(the)]TJ
-1.1128 -1.2203 TD
(racial)Tj
/F3 1 Tf
2.3901 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnic)-332.4(distribution)-338.3(of)-332(their)-330.5(participants,)-339.8(and)-328.4(when)-337.1(re-)]TJ
-2.8896 -1.2266 TD
[(ported,)-219.8(black)-219.8(and)-214.6(Hispanic)-220.6(subjects)-221.7(remain)-219.6(underrepresented)]TJ
0 -1.2203 TD
[(in)-481.1(clinical)-483.5(studies)-478.8(relative)-482.5(to)-477.5(their)-482.2(distribution)-483.7(in)-481.1(the)-484.3(U.S.)]TJ
T*
[(population.)-370.7(Slightly)-369.5(more)-361.3(studies)-371.3(reported)-362.9(at)-366.7(least)-365.1(one)-366.5(out-)]TJ
T*
[(come)-296.7(by)-299.7(sex)-294.2(or)-294.3(race)]TJ
/F3 1 Tf
8.7256 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnicity)-296.6(in)-297.8(2009)-295.2(than)-297.6(in)-297.8(2004,)-291.8(although)]TJ
-9.2251 -1.2266 TD
[(these)-321.1(increases)-312.3(did)-319.4(not)-310.1(reach)-318.9(statistical)-316.4(signicance.)-320.6(Perhaps)]TJ
0 -1.2203 TD
[(the)-408.4(most)-406.8(notable)-412.3(change)-408.2(since)-405.8(2004)-409(was)-407.1(an)-401.2(increase)-412.2(in)-405.3(the)]TJ
T*
[(number)-197(of)-192.9(studies)-194.3(that)-193.5(consider)-197.3()86.6(Hispanic)72.8()-191.6(a)0(s)-190.5(a)0(n)-192.6(ethnic)-193.3(rather)]TJ
0 -1.2267 TD
[(than)-316.6(a)-315.7(racial)-309.6(category)-321.3(in)-310.4(accordance)-316.5(with)-318.8(the)-313.6(Ofce)-315.5(of)-313.1(Man-)]TJ
0 -1.2203 TD
[(agement)-283.4(and)-284.1(Budget)-277.7(census)-284.8(categories.)]TJ
6.7246 0 0 5.9768 214.2991 192.7559 Tm
(9)Tj
8.9663 0 0 8.9663 69.7323 177.8456 Tm
[(Although)-457(subgroup)-460.3(analysis)-459.1(and)-454.8(reporting)-459.8(are)-455.4(required)]TJ
-1.1128 -1.2266 TD
[(under)-267.6(the)-263(NIH)-261.3(guidelines)-264.1(only)-260.7(explicitly)-268.3(for)-263.2(phase)-264.7(III)-259.3(clinical)]TJ
0 -1.2203 TD
[(trials,)-277.5(it)-269.6(is)-270.4(also)-272.7(important)-275.3(that)-275.7(such)-277.2(analyses)-272.1(be)-269.9(published)-274.7(for)]TJ
T*
[(other)-626.9(studies)-617.9(to)-622.9(generate)-621.5(hypotheses)-625.2(about)-621.8(sex)-623(and)-619.2(ra-)]TJ
0 -1.2266 TD
(cial)Tj
/F3 1 Tf
1.5049 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnic)-275.5(differences)-277.4(for)-275.8(subsequent)-277.1(studies.)]TJ
6.7246 0 0 5.9768 239.5842 137.9905 Tm
(12,13)Tj
8.9663 0 0 8.9663 257.2157 133.9653 Tm
[(In)-271.1(fact,)-274.5(the)]TJ
-22.0227 -1.2203 TD
[(NIH)-356.2(guidelines)-359(require)-358.3(designers)-352.6(of)-357.3(phase)-359.6(III)-354.1(studies)-352.3(to)-357.3(ex-)]TJ
T*
[(amine)-370.6(data)-375.5(from)-368.2(prior)-375.8(studies)-371.3(to)-370(determine)-375.1(whether)-376.1(or)-370.2(not)]TJ
T*
[(clinically)-447.2(important)-446(sex)-446(or)-439.8(racial)]TJ
/F3 1 Tf
14.783 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnic)-446.2(differences)-448.1(are)-442.7(ex-)]TJ
-15.2825 -1.2266 TD
[(pected.)-297.7(Where)-293.8(the)-294.6(evidence)-294.2(supports)-295.2(the)-294.6(existence)-294.4(of)-294.1(signi-)]TJ
0 -1.2203 TD
[(cant)-1008(differences,)-1013.8(the)-1002.8(study)-1009.6(design)-1001.9(must)-1006(specically)]TJ
T*
[(accommodate)-324.1(this.)-315.1(When)-321.8(the)-313.6(evidence)-319.5(is)-321(inconclusive,)-322.1(how-)]TJ
0 -1.2267 TD
[(ever,)-225.5(the)-225.1(study)-225.5(design)-224.2(should)-224(address)-223.7(the)-225.1(possibility)-219.9(but)-227.5(does)]TJ
28.0042 74.5598 TD
[(not)-575.7(need)-581.6(to)-578.6(be)-579.7(powered)-578.3(to)-578.6(detect)-584.7(subgroup)-580.4(differences.)]TJ
0 -1.2203 TD
[(Consequently,)-312.5(the)-307.3(lack)-303.9(of)-306.7(analysis)-307.4(and)-303.1(reporting)-308.1(for)-307.4(sex)-306.9(and)]TJ
0 -1.2266 TD
(racial)Tj
/F3 1 Tf
2.3837 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnic)-243.9(differences)-245.8(in)-240.9(preliminary)-245.8(studies)-244.8(could)-243.9(become)]TJ
-2.8832 -1.2203 TD
[(the)-212.4(basis)-218.7(for)-218.9(the)-212.4(failure)-217.7(to)-218.2(conduct)-218.2(and)-214.6(report)-214.6(such)-220.3(analyses)-215.2(in)]TJ
T*
[(subsequent)-283.4(research.)]TJ
1.1128 -1.2266 TD
[(Observers)-315.5(of)-313.1(trends)-318.6(in)-310.4(clinical)-319.1(research)-314.5(caution)-320.1(that)-313.7(when)]TJ
-1.1128 -1.2203 TD
[(researchers)-259.5(do)-252.4(nd)-256(subgroup)-264.3(differences,)-261.4(they)-254.8(frequently)-258.8(fail)]TJ
T*
[(to)-306.7(distinguish)-307.5(between)-306.8(biological)-305.5(and)-303.1(social)-307.1(causes)-306.2(of)-306.7(differ-)]TJ
0 -1.2266 TD
[(ence,)-334.2(essentially)-330.6(portraying)-337.4(differences)-334.3(as)-329.6(biologically)-338.8(inevi-)]TJ
0 -1.2203 TD
[(table)-305(and)-309.4(drawing)-307(attention)-311.1(away)-308.6(from)-305(the)-313.6(social)-307.1(constructs)]TJ
T*
[(that)-421.2(cause)-418.7(observed)-417.4(health)-421.2(disparities.)]TJ
6.7246 0 0 5.9768 466.129 620.1636 Tm
(14)Tj
8.9663 0 0 8.9663 476.6172 616.1951 Tm
[(We)-416.2(agree)-421.7(that)-421.2(the)]TJ
-18.4882 -1.2203 TD
[(analysis)-250.5(and)-252.5(interpretation)-260.4(of)-249.8(differences)-258.4(between)-256.2(subgroups)]TJ
0 -1.2266 TD
[(requires)-296.3(a)-290.4(nuanced)-294.4(approach)-298.7(that)-294.7(considers)-293.4(nonbiological)-296.1(as)]TJ
0 -1.2203 TD
[(well)-375.3(as)-380.2(biological)-381.4(explanations;)-384.2(however,)-385(the)-376.8(complexity)-388(of)]TJ
T*
[(etiologies)-414.2(should)-413.7(not)-417.6(be)-415.3(considered)-415.1(an)-413.9(excuse)-414.9(for)-414.9(not)-411.3(ana-)]TJ
0 -1.2266 TD
[(lyzing)-429.8(sex)-427(or)-427.1(racial)-429.7(differences)-435.5(and,)-426.1(in)-430.6(some)-425.2(cases,)-434.2(gender)]TJ
0 -1.2203 TD
(differences.)Tj
1.1128 -1.2203 TD
[(One)-252.9(study)-250.8(in)-253.5(the)-256.7(present)-253.6(analysis)-256.8(that)-250.4(presented)-262.8(results)-255.2(by)]TJ
-1.1128 -1.2266 TD
[(both)-358.8(sex)-363.8(and)-366.3(race)-359.8(provides)-361.1(an)-363.3(example)-364.3(for)-364.3(the)-364.2(reporting)-365(of)]TJ
0 -1.2203 TD
[(subgroup)-207.4(differences)-207.9(in)-202.9(a)-201.8(thoughtful)-211.3(way.)-204.5(In)-201.5(the)-206.1(discussion)-210.5(of)]TJ
T*
[(why)-275(black)-276.7(and)-277.8(female)-279.1(patients)-281.8(are)-278.3(at)-278.2(greater)-277.5(risk)-275.5(for)-282.2(adverse)]TJ
T*
[(outcomes)-460.7(after)-462.6(vein)-462.8(bypass)-461.3(surgery,)-458.3(the)-465.3(authors)-458.4(acknowl-)]TJ
0 -1.2266 TD
[(edged)-339(the)-338.9(possibility)-340(that)-339(differential)-340.9(clinical)-338.1(outcomes)-346.9(may)]TJ
0 -1.2203 TD
[(be)-225.6(the)-225.1(result)-228.6(of)-224.5(biological)-229.6(differences)-233.2(or)-224.8(underlying)-230(social)-224.9(and)]TJ
T*
[(economic)-280.4(disparities)-283.7(associated)-288.8(with)-280.9(race)-277.6(and)-284.1(gender.)]TJ
6.7246 0 0 5.9768 522.9353 466.7527 Tm
(15)Tj
8.9663 0 0 8.9663 320.8251 451.7857 Tm
[(The)-202.3(major)-214.2(limitation)-208(to)-205.6(our)-213.5(study)-206.6(is)-207.2(that)-212.5(in)-202.9(selecting)-211.8(studies)]TJ
-1.1128 -1.2203 TD
[(published)-350.6(in)-348.4(nine)-351.6(of)-344.7(the)-351.5(highest)-351.5(impact)-349.5(journals,)-349.2(we)-349.3(do)-347.2(not)]TJ
T*
[(cover)-199.4(the)-199.8(whole)-200.9(body)-198(of)-199.3(NIH-funded)-197(RCTs.)-201.3(This)-200.9(may)-197.5(account)]TJ
0 -1.2266 TD
[(for)-332.7(the)-332.5(differences)-334.3(seen)-333.3(in)-329.4(reporting)-339.7(between)-332.1(this)-331.2(study)-333(and)]TJ
0 -1.2203 TD
[(the)-414.7(NIH)-413.1(tracking)-414.1(report)-416.9(for)-414.9(inclusion)-414.1(of)-414.2(women)-416.2(in)-411.6(clinical)]TJ
T*
(studies.)Tj
6.7246 0 0 5.9768 340.8944 400.9889 Tm
(4)Tj
8.9663 0 0 8.9663 347.9243 397.0204 Tm
[(However,)-413.2(the)-408.4(selected)-412(journals)-409.5(were)-413.1(the)-408.4(same)-409.3(set)]TJ
-4.1352 -1.2266 TD
[(evaluated)-279.8(in)-285.1(our)-276.7(earlier)-286(study.)]TJ
1.1128 -1.2203 TD
[(If)-325.1(it)-320.2(is)-327.3(the)-326.2(case)-328.8(\(as)-323.8(we)-324(believe)-328.1(it)-326.5(is\))-321.5(that)-326.3(there)-333.1(is)-321(no)-328.6(willful)]TJ
-1.1128 -1.2203 TD
[(intent)-207.2(to)-205.6(be)-206.6(noncompliant)-210.7(with)-205(Congressional)-210.1(mandates,)-209.9(why)]TJ
T*
[(is)-340(there)-352.1(a)-341(continued)-345.9(lack)-348.2(of)-338.4(appropriate)-352.6(attention)-349(to)-344.7(the)-345.2(un-)]TJ
0 -1.2266 TD
[(derrepresentation)-185.3(of)-186.6(women)-182.3(and)-176.6(ethnic)]TJ
/F3 1 Tf
16.9644 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(minority)-187.1(participants)]TJ
-17.4639 -1.2203 TD
[(in)-557(the)-553.8(reporting)-561(of)-559.7(clinical)-559.4(research?)-560.4(Difculty)-554.9(recruiting)]TJ
T*
[(women)-201.3(and)-201.9(nonwhite)-208.2(participants)-210.4(into)-206.2(clinical)-205.3(research)-207(is)-200.9(one)]TJ
0 -1.2266 TD
[(issue)-260.3(that)-256.8(is)-264.1(receiving)-262(considerable)-261.5(and)-258.8(appropriate)-264.1(attention)]TJ
0 -1.2203 TD
[(through)-357.9(such)-359.4(initiatives)-355(as)-354.9(the)-357.8(Community)-359(Engagement)-357.4(as-)]TJ
T*
[(pects)-248.9(of)-249.8(the)-256.7(NIH)-248.7(Clinical)-250.4(and)-252.5(Translational)-251.8(Science)-250.4(Awards)]TJ
6.7246 0 0 5.9768 543.1747 291.4015 Tm
(16)Tj
8.9663 0 0 8.9663 310.8472 276.4345 Tm
[(and)-239.8(the)-237.7(growing)-242.2(awareness)-241.1(of)-237.2(the)-237.7(importance)-242.4(of)-237.2(community-)]TJ
T*
[(based)-280(participatory)-283.2(research.)]TJ
6.7246 0 0 5.9768 424.5731 269.4614 Tm
(17)Tj
8.9663 0 0 8.9663 320.8251 254.5511 Tm
[(Failure)-316.5(to)-313.1(acknowledge)-318.9(the)-319.9(limitations)-316.8(of)-319.4(clinical)-312.8(research)]TJ
-1.1128 -1.2203 TD
[(overwhelmingly)-288.7(involving)-291.6(white)-287.1(males)-286.4(within)-294.1(reports)-291.7(of)-287.8(the)]TJ
0 -1.2266 TD
[(study)-421.6(results)-432.2(is)-422.2(a)-423.1(separate)-426.3(issue.)]TJ
6.7246 0 0 5.9768 443.2818 236.5795 Tm
(18)Tj
8.9663 0 0 8.9663 453.8267 232.611 Tm
[(Multiple)-423.5(examples)-428.9(exist)]TJ
-15.9464 -1.2203 TD
[(across)-207.2(history)-206.3(of)-199.3(the)-206.1(experience)-212.3(and)-201.9(perspectives)-212.1(of)-199.2(low)-203.9(status)]TJ
T*
[(or)-180.5(marginalized)-182.5(groups)-182.6(being)-186.4(ignored.)-178.7(Medical)-184.6(education)-183.9(and)]TJ
0 -1.2267 TD
[(research)-257.6(are)-259.3(also)-260(replete)-258.7(with)-255.6(such)-264.6(examples.)]TJ
6.7246 0 0 5.9768 487.0487 203.7543 Tm
(19,20)Tj
8.9663 0 0 8.9663 504.5101 199.729 Tm
[(Although)-261(it)]TJ
-21.5991 -1.2203 TD
[(remains)-587.6(disappointing,)-597.2(respected)-593.8(scientists)-596.2(who)-589.5(are)-588.1(well)]TJ
T*
[(versed)-258.5(in)-253.5(the)-263(importance)-255.1(of)-262.5(acknowledging)-254.5(the)-263(limitations)-259.9(of)]TJ
0 -1.2266 TD
[(any)-386.7(study)-389.9(have)-389.2(a)-391.5(long)-387.2(historical)-391.1(precedent)-393.6(of)-388.9(failing)-391.4(to)-388.9(ac-)]TJ
0 -1.2203 TD
[(knowledge)-421.3(that)-427.5(their)-425.3(ndings)-426.7(may)-418.8(not)-423.9(be)-427.9(generalizable)-426.4(to)]TJ
T*
[(women)-283.5(or)-275.4(to)-281.4(men)-285.4(from)-279.7(nonwhite)-284(groups.)]TJ
1.1128 -1.2266 TD
[(What)-350.2(are)-354.2(the)-357.8(next)-360(steps)-352.1(for)-358(ensuring)-359.4(enhanced)-359.5(inclusion,)]TJ
-1.1128 -1.2203 TD
[(analysis,)-247.1(and)-239.8(reporting?)-250.5(NIH)]TJ
/F3 1 Tf
12.6964 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ORWH)-246.6(can)-242.5(mandate)-243.6(and)-246.2(track)]TJ
-13.1959 -1.2203 TD
[(inclusion,)-442.3(but)-442.5(they)-438.1(lack)-443(the)-440(ability)-436.7(to)-445.8(require)-440.5(analysis)-440.2(and)]TJ
T*
[(reporting)-409.3(of)-407.9(sex)-408(and)-410.6(race)]TJ
/F3 1 Tf
11.4571 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnicity)-410.4(in)-411.6(publications.)-413.1(Journal)]TJ
-11.9566 -1.2266 TD
[(reviewers)-362.4(and)-360(editors)-359.4(can)-356.3(play)-362.9(an)-357(integral)-363.2(role)-361(in)-354.7(requiring)]TJ
0 -1.2203 TD
[(reporting)-295.4(of)-294.1(these)-295.8(criteria)-298.5(or)-294.3(an)-293.8(adequate)-298.9(explanation)-297.7(\(e.g.,)-291.8(a)]TJ
T*
[(footnote\))-329.6(as)-329.6(to)-325.7(why)-325.6(such)-327.8(reporting)-327.1(is)-327.3(not)-329.1(appropriate.)-330.2(As)-325.2(in)]TJ
0 -1.2267 TD
[(the)-275.6(past,)-271.1(the)-275.6(scientists)-280.1(who)-273.3(conduct)-275.1(and)-271.5(report)-277.8(on)-271.7(the)-275.6(results)]TJ
/F5 1 Tf
-28.0042 77.228 TD
[(SUBGROUP)-342(REPORTING)-335.7(IN)-335.1(FEDERALLY)-335.3(FUNDED)-337.3(CLINICAL)-339.5(TRIALS)-19859.7(319)]TJ
ET
endstream
endobj
59 0 obj
<>/XObject<>/ProcSet [/PDF /Text /ImageB /ImageC /ImageI]/Font<>>>/Thumb 61 0 R/MediaBox[0 0 612 792]/Rotate 0>>
endobj
62 0 obj
<>/ProcSet[/PDF/Text]/Font<>>>
endobj
60 0 obj
<>stream
/GS1 gs
BT
/F7 1 Tf
8.9663 0 0 8.9663 62.022 725.7825 Tm
0 0 0 1 k
0 Tc
0 Tw
[(of)-332(the)-332.5(research)-333.5(have)-326(the)-332.5(greatest)-335.5(responsibility,)-334.3(but)-328.7(they)-330.6(are)]TJ
0 -1.2203 TD
[(not)-360.7(complying.)-364.6(In)-359.6(the)-364.2(CONSORT)-359.7(2010)-358.5(reporting)-365(guidelines)]TJ
0 -1.2266 TD
[(for)-370.7(RCTs,)]TJ
6.7246 0 0 5.9768 100.233 707.8676 Tm
(21)Tj
8.9663 0 0 8.9663 110.2677 703.8423 Tm
[(items)-369.5(20)-372.1(and)-366.3(21)-365.8(in)-367.3(the)-370.5(checklist)-375.5(for)-370.7(authors)-369.9(en-)]TJ
-5.3808 -1.2203 TD
[(courage)-539.1(discussion)-539.3(of)-534.4(limitations)-538.1(and)-530.7(generalizability,)-536.2(re-)]TJ
T*
[(spectively.)-327.2(Perhaps)-323.7(the)-319.9(next)-322.1(CONSORT)-321.8(could)-319.8(be)-320.5(even)-326.4(more)]TJ
0 -1.2266 TD
[(prescriptive)-196.1(and)-189.3(include)-197.4(in)-190.3(these)-194.7(items)-192.5(the)-193.4(directive)-194.4(to)-192.9(authors)]TJ
0 -1.2203 TD
[(to)-439.5(specically)-436(comment)-437.2(on)-436.1(limitations)-436.9(and)-435.9(generalizability)]TJ
T*
[(relative)-413(to)-407.9(the)-408.4(gender)-416(and)-404.2(ethnic)]TJ
/F3 1 Tf
14.9221 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(racial)-410.7(composition)-417.1(of)-407.9(the)]TJ
-15.4216 -1.2266 TD
[(study)-326.7(participants.)-333.5(Then,)-322.4(journal)-332.4(editors)-327.8(could)-326.1(insist)-323.4(that)-332.6(all)]TJ
0 -1.2203 TD
[(reports)-285.4(of)-281.4(clinical)-281.2(trials)-280.9(follow)-286.6(the)-282(CONSORT)-277.5(guidelines.)]TJ
1.1128 -1.2203 TD
[(On)-335.2(a)-328.3(positive)-342.4(note,)-331.9(some)-336.7(journals)-333.7(have)-338.7(instituted)-333.6(policies)]TJ
-1.1128 -1.2203 TD
[(about)-305.7(reporting)-308.1(sex)-306.9(and)-309.4(race)]TJ
/F3 1 Tf
12.6964 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnicity.)-312.2(If)-306.1(race)-302.9(or)-307(ethnicity)-309.2(is)]TJ
-13.1959 -1.2266 TD
[(reported)-350.2(in)]TJ
/F11 1 Tf
5.3112 0 TD
(JAMA)Tj
/F7 1 Tf
2.6999 0 TD
[(,)-338(the)-345.2(authors)-351(must)-342.1(explain)-348.5(why)-344.5(it)-345.4(was)-343.9(as-)]TJ
-8.0111 -1.2203 TD
[(sessed)-424.1(and)-416.9(describe)-416.7(the)-421.1(classications)-420.1(used,)-419.5(who)-418.8(classied)]TJ
T*
[(participants)-488.6(as)-487.7(to)-483.8(race)]TJ
/F3 1 Tf
10.2305 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnicity,)-489.2(and)-486.4(whether)-489.9(the)-484.3(options)]TJ
-10.73 -1.2266 TD
[(were)-204.5(dened)-201.9(by)-204.8(the)-199.8(investigator)-204.1(or)-205.8(the)-199.8(participant.)]TJ
/F11 1 Tf
22.0986 0 TD
(Circulation)Tj
/F7 1 Tf
-22.0986 -1.2203 TD
[(asks)-297.4(authors)-294(to)-294.1(provide)-296.5(subanalyses)-298.2(by)-293.4(sex)-294.2(or)-294.3(race)]TJ
/F3 1 Tf
22.3578 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
(ethnicity)Tj
-22.8573 -1.2203 TD
[(when)-368.7(appropriate)-371.6(or)-363.9(to)-363.6(specically)-372.7(state)-368.4(that)-364.2(their)-368.4(analyses)]TJ
0 -1.2266 TD
[(did)-502.7(not)-499.8(detect)-508.9(subgroup)-498.2(difference.)-506.6(The)-505.8(journal)]TJ
/F11 1 Tf
22.6171 0 TD
(Nature)Tj
/F7 1 Tf
3.3511 0 TD
(is)Tj
-25.9682 -1.2203 TD
[(working)-356(on)-353.9(a)-353.6(policy)-350(change)-357.6(that)-351.6(requires)-359.6(authors)-357.3(to)-351(clearly)]TJ
T*
[(label)-200.6(single-sex)-203.3(studies)-200.6(and)-195.6(to)-199.3(justify)-199.9(including)-202.5(only)-197.5(one)-202.1(sex)-199.4(in)]TJ
T*
[(their)-532.8(research)-535.8(design)-540.3(\(personal)-531.4(communication\))-539.7(following)]TJ
0 -1.2266 TD
[(publication)-396.2(of)-395.3(an)-388.6(opinion)-400.1(piece)-389.7(urging)-397.2(such)-391(a)-391.5(policy.)]TJ
6.7246 0 0 5.9768 277.7385 488.6361 Tm
(22)Tj
8.9663 0 0 8.9663 287.9432 484.6676 Tm
(We)Tj
-25.1968 -1.2203 TD
[(applaud)-515.5(these)-517.1(journals)-517(for)-516.1(taking)-515.2(important)-521.9(and)-511.7(tangible)]TJ
T*
[(steps)-314.2(toward)-317.9(enhanced)-315.3(inclusion,)-315.9(analysis,)-310.3(and)-315.7(reporting)-314.4(by)]TJ
0 -1.2266 TD
[(sex)-376.4(and)-379(racial)]TJ
/F3 1 Tf
6.2091 0 TD
(=)Tj
/F7 1 Tf
.4995 0 TD
[(ethnic)-383(categories)-384.8(and)-372.6(encourage)-384.3(them)-374.4(to)-382.6(en-)]TJ
-6.7086 -1.2203 TD
[(force)-281.3(these)-283.2(policies.)]TJ
/F5 1 Tf
0 -2.447 TD
(Conclusions)Tj
/F7 1 Tf
1.1128 -1.8336 TD
[(Given)-227.6(the)-231.4(ongoing)-227(focus)-232.8(by)-223.8(NIH)-229.7(and)-227.2(others)-229.8(over)-231.7(the)-231.4(past)-230.3(5)]TJ
-1.1128 -1.2203 TD
[(years)-322(for)-320.1(inclusion)-325.6(of)-325.7(women)-321.4(and)-322(underrepresented)-328.7(minori-)]TJ
T*
[(ties)-371.9(in)-373.6(clinical)-376(trials,)-372.4(we)-374.6(expected)-379(to)-370(see)-374.2(greater)-378.6(compliance)]TJ
T*
[(with)-236.6(the)-237.7(guidelines,)-235.4(but)-240.2(for)-231.6(these)-238.9(nine)-237.8(inuential)-236.6(journals,)-241.7(we)]TJ
0 -1.2266 TD
[(found)-282.9(little)-283.3(improvement.)]TJ
/F5 1 Tf
0 -2.4406 TD
[(Disclosure)-336.7(Statement)]TJ
/F7 1 Tf
1.1128 -1.8336 TD
[(The)-278.2(authors)-287.7(have)-281.7(no)-278(conicts)-284.9(of)-281.4(interest)-287.9(to)-281.5(report.)]TJ
/F5 1 Tf
-1.1128 -2.447 TD
(References)Tj
/F7 1 Tf
8.4682 0 0 8.4682 66.274 282.3307 Tm
[(1.)-501.9(National)-385.3(Institutes)-387(of)-382.2(Health.)-386.8(NIH)-386.3(guidelines)-384.6(on)-386.6(the)-385.3(inclu-)]TJ
1.2519 -1.2385 TD
[(sion)-252(of)-248.3(women)-252.6(and)-252.1(minorities)-251(as)-248.9(subjects)-255.8(in)-251.6(clinical)-250.6(research.)]TJ
0 -1.2318 TD
[(Fed)-330.9(Regist)-334.4(1994;59:14508)-7.4(14513.)]TJ
-1.2519 -1.2385 TD
[(2.)-501.9(Ofce)-340.4(of)-342.1(Extramural)-347.3(Research)-345.9(NIH.)-343.8(NIH)-346.1(policy)-341.1(and)-345.8(guide-)]TJ
1.2519 -1.2318 TD
[(lines)-251.5(on)-259.4(the)-251.5(inclusion)-263.8(of)-255(women)-252.6(and)-258.8(minorities)-257.7(as)-255.6(subjects)-255.8(in)]TJ
0 -1.2385 TD
[(clinical)-458.2(researchAmended,)-458.8(October)-463.9(2001.)-454.7(Department)-455.8(of)]TJ
0 -1.2318 TD
[(Health)-389.1(and)-392.7(Human)-387.1(Services,)-397.3(National)-392(Institutes)-400.4(of)-388.9(Health.)]TJ
0 -1.2385 TD
[(Available)-678.8(at)-677.6(grants.nih.gov)]TJ
/F3 1 Tf
12.7067 0 TD
(=)Tj
/F7 1 Tf
.5021 0 TD
(grants)Tj
/F3 1 Tf
2.7516 0 TD
(=)Tj
/F7 1 Tf
.5021 0 TD
(funding)Tj
/F3 1 Tf
3.4947 0 TD
(=)Tj
/F7 1 Tf
.5021 0 TD
(women_min)Tj
/F3 1 Tf
5.5232 0 TD
(=)Tj
/F7 1 Tf
-25.9825 -1.2318 TD
[(guidelines_amended_10_2001.htm)-640.3(Accessed)-636.9(November)-642.7(6,)]TJ
0 -1.2385 TD
(2009.)Tj
-1.2519 -1.2318 TD
[(3.)-501.9(NIH)]TJ
/F3 1 Tf
3.2269 0 TD
(=)Tj
/F7 1 Tf
.5021 0 TD
[(ORWH.)-444.3(Ofce)-440.8(of)-442.5(Research)-439.6(on)-440.2(Womens)-443.9(Health)-442.7(out-)]TJ
-2.4771 -1.2385 TD
[(reach)-295.8(publications.)-299.2(Available)-297.2(at)-296(orwh.od.nih.gov)]TJ
/F3 1 Tf
21.5036 0 TD
(=)Tj
/F7 1 Tf
.4954 0 TD
(inclusion)Tj
/F3 1 Tf
3.9834 0 TD
(=)Tj
/F7 1 Tf
-25.9825 -1.2385 TD
[(incloutreach.html)-338.1(Accessed)-342.3(September)-336.6(9,)-334.6(2010.)]TJ
-1.2519 -1.2318 TD
[(4.)-501.9(NIH)-620.6(Tracking)]TJ
/F3 1 Tf
7.7325 0 TD
(=)Tj
/F7 1 Tf
.5021 0 TD
[(Inclusion)-626.9(Committee.)-627.5(Tracking)-622.6(of)-623.2(human)]TJ
-6.9827 -1.2385 TD
[(subjects)-423.2(research)-426.1(as)-429.7(reported)-425(in)-425.7(scal)-419.8(year)-424.8(2006)-423.5(and)-426.2(scal)]TJ
0 -1.2318 TD
[(year)-337.8(2007.)-340.9(Department)-348.6(of)-348.8(Health)-342.2(and)-345.8(Human)-340.2(Services,)-350.4(Na-)]TJ
0 -1.2385 TD
[(tional)-334.9(Institutes)-340.1(of)-335.4(Health,)-339.9(2008.)]TJ
-1.2519 -1.2318 TD
[(5.)-501.9(Geller)-557.1(SE,)-560.8(Adams)-557.3(MG,)-556.9(Carnes)-566.2(M.)-553.6(Adherence)-565(to)-563(federal)]TJ
1.2519 -1.2385 TD
[(guidelines)-331(for)-332(reporting)-339.7(of)-328.7(sex)-333.3(and)-332.4(race)]TJ
/F3 1 Tf
17.5805 0 TD
(=)Tj
/F7 1 Tf
.5021 0 TD
[(ethnicity)-337.1(in)-332(clinical)]TJ
-18.0826 -1.2318 TD
[(trials.)-330(J)-340.8(Womens)-332.3(Health)-335.5(2006;15:11231)-7.4(131.)]TJ
28.3926 75.8385 TD
[(6.)-501.9(Vidaver)-492.2(RM,)-496.9(Laeur)-494.7(B,)-491.7(Tong)-496(C,)-494.8(Bradshaw)-493.3(R,)-489.9(Marts)-499.5(SA.)]TJ
1.2519 -1.2318 TD
[(Women)-386.8(subjects)-383(in)-385.5(NIH-funded)-389.3(clinical)-384.5(research)-392.6(literature:)]TJ
0 -1.2385 TD
[(Lack)-236.8(of)-234.9(progress)-240.8(in)-231.6(both)-242.4(representation)-241.1(and)-238.7(analysis)-237.8(by)-235(sex.)-237.2(J)]TJ
0 -1.2318 TD
[(Womens)-339(Health)-335.5(Gend)-334.2(Based)-333.6(Med)-340.9(2000;9:495504.)]TJ
-1.2519 -1.2385 TD
[(7.)-501.9(Corbie-Smith)-338.9(G,)-335.7(St)-336.3(George)-334.1(DM,)-339.3(Moody-Ayers)-339(S,)-334.6(Ransohoff)]TJ
1.2519 -1.2318 TD
[(DF.)-463.2(Adequacy)-464.8(of)-469.3(reporting)-466.9(race)]TJ
/F3 1 Tf
14.6683 0 TD
(=)Tj
/F7 1 Tf
.4954 0 TD
[(ethnicity)-471(in)-465.9(clinical)-464.9(trials)]TJ
-15.1637 -1.2385 TD
[(in)-566.3(areas)-569.6(of)-563(health)-572.2(disparities.)-572.2(J)-561.7(Clin)-568.1(Epidemiol.)-571.2(2003;56:)]TJ
0 -1.2318 TD
(416420.)Tj
-1.2519 -1.2385 TD
[(8.)-501.9(Ramasubbu)-390(K,)-391(Gurm)-393(H,)-387.5(Litaker)-396.1(D.)-385.9(Gender)-398.4(bias)-386.6(in)-392.2(clinical)]TJ
1.2519 -1.2318 TD
[(trials:)-457.2(Do)-463.1(double)-455.7(stand)-9.5(ards)-458.3(still)-454.2(apply?)-465(J)-454.6(Womens)-459.5(Health)]TJ
0 -1.2385 TD
[(Gend)-334.2(Based)-333.6(Med)-340.9(2001;10:757764.)]TJ
-1.2519 -1.2318 TD
[(9.)-501.9(Revisions)-456.6(to)-455.9(the)-452.3(standards)-461.1(for)-452.5(the)-452.3(classication)-457.4(of)-455.9(federal)]TJ
1.2519 -1.2385 TD
[(data)-330.2(on)-339.8(race)-332.3(and)-332.4(ethnicity.)-334.8(Fed)-337.6(Regist)-334.4(1997;62:5878158790.)]TJ
-1.754 -1.2318 TD
[(10.)-504(Kim)-435.7(ES,)-440.3(Carrigan)-435.2(TP,)-434.2(Menon)-444.9(V.)-431.2(Enrollment)-441.5(of)-442.5(women)-433.3(in)]TJ
1.754 -1.2385 TD
[(National)-485.8(Heart,)-486.6(Lung,)-481.8(and)-479.7(Blood)-488.5(Institute-funded)-491.3(cardio-)]TJ
0 -1.2318 TD
[(vascular)-416.5(randomized)-414.2(controlled)-415.1(trials)-412.6(fails)-416(to)-415.7(meet)-411(current)]TJ
0 -1.2385 TD
[(federal)-393.1(mandates)-395.9(for)-392.2(inclusion.)-395.4(J)-394.3(A)0(m)-390.2(Coll)-391.6(Cardiol)-395.5(2008;52:)]TJ
0 -1.2318 TD
(672673.)Tj
-1.754 -1.2385 TD
[(11.)-504(Blauwet)-449.4(LA,)-438(Hayes)-448.8(SN,)-443.2(McManus)-448.4(D,)-446.2(Redberg)-442.4(RF,)-446.7(Walsh)]TJ
1.754 -1.2385 TD
[(MN.)-381.1(Low)-371.9(rate)-380.3(of)-382.2(sex-specic)-383.8(result)-380.3(reporting)-379.8(in)-378.8(cardiovas-)]TJ
0 -1.2318 TD
[(cular)-334.6(trials.)-336.7(Mayo)-335.4(Clin)-333.8(Proc)-340.3(2007;82:166170.)]TJ
-1.754 -1.2385 TD
[(12.)-504(Uhl)-526(K,)-518.2(Parekh)-531.8(A,)-519.8(Kweder)-527.5(S.)-522.1(Females)-523.8(in)-526.1(clinical)-525.1(studies:)]TJ
1.754 -1.2318 TD
[(Where)-313.8(are)-314(we)-312.4(going?)-312(Clin)-313.7(Pharmacol)-317(Ther)-314.2(2007;81:600602.)]TJ
-1.754 -1.2385 TD
[(13.)-504(Wang)-502.5(R,)-510(Lagakos)-505.9(SW,)-499.5(Ware)-505.7(JH,)-507.3(Hunter)-506.8(DJ,)-505.8(Drazen)-507.2(JM.)]TJ
1.754 -1.2318 TD
[(Statistics)-467.7(in)-465.9(medicineReporting)-468.7(of)-462.6(subgroup)-468.1(analyses)-465.9(in)]TJ
0 -1.2385 TD
[(clinical)-337.7(trials.)-336.7(N)-329.5(Engl)-340.9(J)-334.1(Med)-334.2(2007;357:21892194.)]TJ
-1.754 -1.2318 TD
[(14.)-504(Epstein)-486.4(S.)-488.6(Inclusion:)-484(The)-485(politics)-490(of)-489.3(difference)-486.6(in)-486(medical)]TJ
1.754 -1.2385 TD
[(research.)-336.7(Chicago:)-336.6(The)-337.7(University)-338.5(of)-335.4(Chicago)-338.9(Press,)-337.4(2007.)]TJ
-1.754 -1.2318 TD
[(15.)-504(Nguyen)-538.2(LL,)-543.8(Hevelone)-537.8(N,)-541.4(Rogers)-540.3(SO,)-537.8(et)-542.3(al.)-535.6(Disparity)-539.5(in)]TJ
1.754 -1.2385 TD
[(outcomes)-613.9(of)-616.6(surgical)-612.1(revascularization)-623.6(for)-613.2(limb)-608.6(salvage:)]TJ
0 -1.2318 TD
[(Race)-379.3(and)-379.3(gender)-378.7(are)-374.3(synergistic)-386(determinants)-380.9(of)-382.2(vein)-379.8(graft)]TJ
0 -1.2385 TD
[(failure)-336.7(and)-332.4(limb)-334.1(loss.)-338.8(Circulation)-341(2009;119:123130.)]TJ
-1.754 -1.2318 TD
[(16.)-504(Department)-502.6(of)-502.7(Health)-496.2(and)-499.8(Human)-500.9(Services,)-504.4(National)-499.2(In-)]TJ
1.754 -1.2385 TD
[(stitutes)-528.8(of)-522.8(Health.)-520.7(Institutional)-535.4(Clinical)-521.9(and)-519.9(Translational)]TJ
0 -1.2318 TD
[(Science)-338.5(Award,)-333.5(RFA-RM-07-002.)-338.5(2006.)]TJ
-1.754 -1.2385 TD
[(17.)-504(Shalowitz)-242.6(MU,)-238.9(Isacco)-241.6(A,)-238.6(Barquin)-242(N,)-240.2(et)-241(al.)-241(Community-based)]TJ
1.754 -1.2318 TD
[(participatory)-701.5(research:)-704.9(A)-696.2(review)-698.5(of)-696.9(the)-700(literature)-708.2(with)]TJ
0 -1.2385 TD
[(strategies)-355.5(for)-352.1(community)-354.7(engagement.)-359.4(J)-347.5(Dev)-355.7(Behav)-346.8(Pediatr)]TJ
0 -1.2318 TD
(2009;30:350361.)Tj
-1.754 -1.2385 TD
[(18.)-504(Dresser)-307.2(R.)-302.5(Wanted:)-307.6(Single,)-302.9(white)-309(male)-299.5(for)-305.2(medical)-309.8(research.)]TJ
1.754 -1.2318 TD
[(Hastings)-336.7(Cent)-340.1(Rep)-335(1992;22:2429.)]TJ
-1.754 -1.2385 TD
[(19.)-504(Mendelsohn)-400.2(KD,)-397.6(Nieman)-405.2(LZ,)-394.7(Isaacs)-397.3(K,)-397.7(Lee)-401.5(S,)-394.9(Levison)-398.8(SP.)]TJ
1.754 -1.2318 TD
[(Sex)-296.2(and)-299(gender)-305.1(bias)-299.6(in)-298.5(anatomy)-302.2(and)-299(physical)-297.9(diagnosis)-302.4(text)]TJ
0 -1.2385 TD
[(illustrations.)-343.3(JAMA)-334.2(1994;272:12671270.)]TJ
-1.754 -1.2318 TD
[(20.)-504(Carnes)-546.1(M,)-540.3(Morrissey)-546.4(C,)-541.6(Geller)-550.4(SE.)-540.7(Womens)-544.4(health)-545.4(and)]TJ
1.754 -1.2385 TD
[(womens)-282.9(leadership)-285.7(in)-278.4(academic)-283.1(medicine:)-283(Hitting)-282.4(the)-278.2(same)]TJ
0 -1.2318 TD
[(glass)-332.2(ceiling?)-339.7(J)-334.1(Womens)-339(Health)-335.5(2008;17:14531462.)]TJ
-1.754 -1.2385 TD
[(21.)-504(Schulz)-477.9(KF,)-475.1(Altman)-476(DG,)-469.5(Moher)-477.9(D.)-472.9(CONSORT)-480.5(2010)-470.4(state-)]TJ
1.754 -1.2318 TD
[(ment:)-358.3(Updat)-9.4(ed)-354(guidelines)-364.5(for)-365.5(reporting)-366.4(parallel)-359.7(group)-362.1(ran-)]TJ
0 -1.2385 TD
[(domized)-338(trials.)-336.7(Ann)-335.5(Intern)-333.9(Med)-334.2(2010;152:7267)-7.4(32.)]TJ
-1.754 -1.2318 TD
[(22.)-504(Kim)-375.5(A,)-372.5(Tingen)-378.7(C,)-374.3(Woodruff)-378.4(T.)-377.8(Sex)-376.5(bias)-373.3(in)-378.8(trials)-379.1(and)-372.6(treat-)]TJ
1.754 -1.2385 TD
[(ment)-333.8(must)-338(end.)-335.4(Nature)-337.7(2010;465:688689.)]TJ
8.9663 0 0 8.9663 441.5243 157.0393 Tm
[(Address)-339.4(correspondence)-340.1(to:)]TJ
/F11 1 Tf
3.0729 -1.2203 TD
[(Stacie)-334.2(E.)-334.7(Geller,)-334.1(Ph.D.)]TJ
1.2709 -1.2203 TD
[(College)-337(of)-336.3(Medicine)]TJ
-4.4703 -1.2266 TD
[(820)-333.6(S.)-336.1(Wood)-332(Street)-336.2(\()-82.7(M)0(C)-338.1(808\))]TJ
.1707 -1.2203 TD
[(University)-333.7(of)-336.3(Illinois,)-337.8(Chicago)]TJ
4.7864 -1.2203 TD
[(Chicago,)-340.4(IL)-333.7(60612)]TJ
-2.5671 -2.0549 TD
(E-mail:)Tj
/F7 1 Tf
3.2563 0 TD
(sgeller@uic.edu)Tj
/F5 1 Tf
-47.8455 74.2563 TD
(320)Tj
47.0425 0 TD
[(GELLER)-335.4(ET)-338.7(AL.)]TJ
ET
endstream
endobj
63 0 obj
[/Indexed/DeviceRGB 255 64 0 R]
endobj
64 0 obj
<>stream
8;X]O>EqN@%''O_@%e@?J;%+8(9e>X=MR6S?i^YgA3=].HDXF.R$lIL@"pJ+EP(%0
b]6ajmNZn*!='OQZeQ^Y*,=]?C.B+\Ulg9dhD*"iC[;*=3`oP1[!S^)?1)IZ4dup`
E1r!/,*0[*9.aFIR2&b-C#soRZ7Dl%MLY\.?d>Mn
6%Q2oYfNRF$$+ON<+]RUJmC0InDZ4OTs0S!saG>GGKUlQ*Q?45:CI&4J'_2j$XKrcYp0n+Xl_nU*O(
l[$6Nn+Z_Nq0]s7hs]`XX1nZ8&94a\~>
endstream
endobj
65 0 obj
<>stream
hޔXytSպГ 䜻A""LZI:fl$$Mtc:B)P*DϫKyvv{ĵp9ݕ~os|LV ?7X啓x^|Sux:re61ɵ5Oa=65g*eX>X|X+^e6rX+agV3)Y>,6k+UĢY,8J唉SG-{ڨOO; kNM0ifڬ9:[X3w*z͏}9asxbysd9:-B?J=oּ+88ΝMƅ(l`pYD]x
IZxw gBDp`>@,X5`.STmtz BHpu*hg/p*UwXAE)IՒOs}n3E~o.&CZNosÕ:c0CX\/w\m {g6Ķ/l_PcY`=$ ,KL;=emZeR"S zt>r!K7zsjnXP '2xڇ~g(L'vY5r|G՞Mk~+_\N/=zdTBb3RǹN4`/G5UQ.9*N3(VZ1_jjS7aB+\,?.E=ҭHf@m}l_FsW6$]yv7`#A45~k|v<
{?}yaƀ1EϹtkd&^SVf.ӻg3
$W-_4Jgf 0OnZGࢧSEu᯼6߹A+a֧q=z=LC)xK*G>lo .>ѡcMIVloIJl&AkZe
^IXw_,~~X<|{c'ETHuZmG
tf+f&hu0 ERPADu=ZmQj_eQ;)q|f{`'\PRtjZd\@+VƭԢLPuMxsVLjTFZ
j_/~ҚZBڇOBIf~@?a2*xfɶ7$>#ZW87
gD+0DKo96;qvn+CK~i>NGCfB[o``91X_""ޗB'K9xf]3~V{=m}`c88ܣ!~~MbIM毘|_(C'~n!098hCv `:~ Qo@mؽ@Nh[jw}cl4@jS#Z, quR<(օ1(?;tnQc=t+NuvU:dX
_IE1zC$i+)(f<o
D`*xlq
ͯ|
U$"`p?\'*5r`QvA šo1FDƣuRF5Sn\ͷPr)vP#V U@E^pi2y^ѦP;icab+O_PT2M6F]ojH}~=FlFDw<}?wҞ#ca_D?OS3!N>q _x]?#츏Pa pQp#=L|0IhO.cy2I$ߡqGl
+'>AV~rD^()1I)6ͯIscieAAwUKvtyz)*_Wr|&JW
N~LgfҺLR
G4TuBć&rU|M2α82Q"loB3W7+_`mM%L4IT
?M3ٳ{vDg$d++*KX6(.:vʩP|ҝU5Exy"C-R
2R.SiJ3JOǤ"J":_U
C-o Kq{7e:+ehʈظI*TLs:8jRĚ